etoposide has been researched along with Cancer of Stomach in 315 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (5.71) | 18.7374 |
| 1990's | 152 (48.25) | 18.2507 |
| 2000's | 89 (28.25) | 29.6817 |
| 2010's | 47 (14.92) | 24.3611 |
| 2020's | 9 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Benites, J; Ibacache, A; Rodriguez, JA; Theoduloz, C; Valderrama, JA | 1 |
| Asao, N; Dan, S; Hikita, K; Kaneda, N; Kato, K; Matsuoka, K; Matsuyama, H; Motoyama, Y; Murata, T; Nakayoshi, T; Oda, A; Okunaga, H; Tanaka, H; Yamakage, Y | 1 |
| Albers, D; Kasper, S; Lahner, H; Markus, P; Mende, B; Mika, S; Reis, H; Rosery, V; Schmid, KW; Schuler, M; Schumacher, B; Siveke, JT; Stuschke, M; Treckmann, J; Wiesweg, M | 1 |
| Herng, SC; Htet, NH; Naing, C | 1 |
| Cai, LH; Chen, JP; Fu, WH; Hao, HK; He, QL; Huang, CM; Jiang, LX; Li, E; Li, HL; Li, P; Li, SL; Li, Y; Li, YX; Li, Z; Lin, JP; Lin, JX; Lin, W; Tian, YT; Xie, JW; Xu, YC; Xu, ZK; Xue, FQ; Zhao, G; Zhao, YJ; Zheng, CH; Zhou, XJ; Zhou, YB; Zhu, ZG; Zou, BB | 1 |
| Jiao, N; Shi, L; Wang, B | 1 |
| Afchain, P; Baudin, E; Desgrippes, R; Hadoux, J; Hautefeuille, V; Lepage, C; Lorgis, V; Monterymard, C; Scoazec, JY; Thuillier, F; Tougeron, D; Walter, T | 1 |
| Li, K; Niu, J; Qian, Y; Sun, F; Wang, S; Wu, B; Zhu, R | 1 |
| Cai, J; Chen, X; Cheng, J; Hong, Z; Hou, J; Wang, L; Zhao, J; Zheng, W; Zhuo, H | 1 |
| Bielawska, A; Bielawski, K; Czarnomysy, R; Gornowicz, A; Szymanowski, W | 1 |
| Jing, YX; Qi, SN; Shi, RY; Wang, LS; Yang, YJ; Yao, J; Yuan, HQ | 1 |
| Al-Hanayneh, M; Bilal, M; Shabot, JM; Simoes, C | 1 |
| Barbera, MA; Biasco, G; Bondi, A; Brandi, G; Brighi, N; Campana, D; Corbelli, J; Pantaleo, MA; Paragona, M | 1 |
| Fujita, M; Hashimoto, D; Inaba, Y; Ninomiya, R | 1 |
| Ali, AS; Grönberg, M; Grønbæk, H; Hjortland, GO; Janson, ET; Knigge, U; Ladekarl, M; Langer, SW; Österlund, P; Sorbye, H; Vestermark, LW; Welin, S | 1 |
| Bielawska, A; Bielawski, K; Czarnomysy, R; Gornowicz, A; Pawłowska, N; Surażyński, A; Szymanowska, A | 1 |
| Guenova, ML; Hristoskova, RG; Petkova, NY; Raynov, JI | 1 |
| Boudreaux, JP; Ramirez, RA; Thiagarajan, R; Thomas, KEH; Voros, BA; Woltering, EA | 1 |
| Arai, H; Honda, M; Kobayashi, Y; Yasuhara, Y; Yoshida, K | 1 |
| Arai, E; Futamura, N; Hirata, A; Ishiguro, N; Kozawa, E; Miyahara, R; Nishida, Y; Tsukushi, S; Tsurudome, I; Urakawa, H | 1 |
| Ilson, DH | 1 |
| Cui, J; Dong, W; Li, W; Liu, Y; Lu, Y; Xing, R; Yan, Z; Zhang, J; Zhang, X | 1 |
| Liu, H; Shan, Y; Tian, YT; Wang, CF; Xie, YB; Xu, Q; Yuan, XH; Zhang, JW; Zhao, DB; Zhou, ZX | 1 |
| Elsing, C; Hannig, CV; Herrmann, C; Herrmann, T; Jäger, D; Stremmel, W | 1 |
| Liu, H; Sun, X; Wang, J; Wang, SL; Zhu, R; Zhu, Y | 1 |
| Kim, MS; Lee, DY | 1 |
| Boetticher, NC; Strickler, JG; Toma, AA; Verma, R | 1 |
| Huang, JA; Lai, MY; Liu, SQ; Mao, YB; Qin, MB; Tan, L; Xu, CY; Zhuge, CF | 1 |
| Jiang, H; Li, J; Li, Z; Liu, N; Pei, L; Zhang, S | 1 |
| He, Q; Ji, X; Li, G; Li, Y; Ma, L | 1 |
| Choe, AR; Choi, JE; Lee, KE; Nam, EM; Park, H; Yoon, SE | 1 |
| Fazio, N; Milione, M | 1 |
| Cao, J; Geng, D; Jiang, H; Li, Z; Liu, H | 1 |
| Hosoda, Y; Imamura, M; Kawai, J; Kiyochi, H; Komoto, I; Nishiyama, K; Ogura, N; Okabe, A; Oshima, Y; Sugimoto, T; Taki, Y; Tsunekawa, S | 1 |
| Barone, C; Biondi, A; Cananzi, FC; D'Ugo, D; Persiani, R; Pozzo, C; Rausei, S; Schinzari, G | 1 |
| Kinukawa, N; Kunoki, N; Moriyama, M; Nishiyama, R; Ogawa, M; Ogihara, A; Oonishi, M; Ryuzaki, H; Sou, K; Tanaka, N; Uno, A; Yamamoto, T | 1 |
| Cordier, JF; Cottin, V; Girard, N; Lapalus, MG; Tronc, F | 1 |
| Carocha, AP; Issa, MC; Pereira, GB; Pinto, JM; Vergueiro, Tde R; Vilar, EG; Xavier, MH | 1 |
| Druck, P; Gupta, P; Iwamoto, C; Mesa, H; Niehans, GA; Rawal, A; Rezcallah, A | 1 |
| Drew, PA; Jamieson, GG; Liu, JF; Wu, TC; Zhu, GJ | 1 |
| Fujime, M; Hojo, M; Kato, J; Kodani, T; Nagahara, A; Nagao, K; Ogihara, T; Osada, T; Otaka, M; Saito, H; Shibuya, T; Ueyama, H; Watanabe, S | 1 |
| Lou, F; Pan, HM; Zhu, YH | 1 |
| Hou, KZ; Liu, YP; Qu, XJ; Teng, YE; Yang, XH; Zhang, JD; Zhang, Y | 1 |
| Grün, R; Koch, B; Tannapfel, A; Vieth, M | 1 |
| Alici, S; Benekli, M; Buyukberber, S; Camci, C; Coskun, U; Dane, F; Gumus, M; Kalender, ME; Kaya, AO; Ozturk, B; Sevinc, A; Uncu, D; Yaman, E; Yildiz, R | 1 |
| Fujii, M; Funada, T; Kaiga, T; Kanamori, N; Kochi, M; Takahashi, T; Takayama, T | 1 |
| Chao, Y; Kuo, SC; Lee, KC; Lee, RC; Li, AF; Li, CP; Luo, JC; Wu, CW | 1 |
| Chen, XM; Huang, ZG; Wang, ZR; Zhang, DW; Zhang, X; Zhu, FS | 1 |
| Bazin, IS; Fedyanin, MY; Garin, AM; Kanagavel, D; Narimanov, MN; Pokataev, IA; Tjulandin, SA; Tryakin, AA; Yakovleva, ES | 1 |
| Bobrzynski, L; Dadan, J; Drews, M; Jedrys, J; Jeziorski, A; Kolodziejczyk, P; Krawczyk, M; Kulig, J; Popiela, T; Sierzega, M; Starzynska, T; Wallner, G | 1 |
| Cho, SJ; Choi, JS; Kim, HY; Lee, SK; Lee, WH; Park, BD; Park, JH; Surh, YJ | 1 |
| Briend, D; Daaboul, M; Ferrand, L; Gazut, V; Kunin, N; Letoquart, JP; Moreau, L; Perrouin-Verbe, MA | 1 |
| Davis, D; Guha, S; Richards, D; Yan, P | 1 |
| Hirakawa, K; Miwa, A; Qiu, H; Yashiro, M; Zhang, X | 1 |
| Baek, KE; Cho, HJ; Choi, J; Choi, YL; Im, MJ; Kang, SS; Kim, IK; Kim, JW; Lee, CW; Nam, IK; Park, SH; Park, SM; Ryu, J; Yoo, J | 1 |
| Chen, GQ; Chen, XH; Gu, QL; Liu, BY; Liu, CX; Qu, Y; Wei, M; Wu, YL; Yan, M; Yang, ZY; Zhang, Q; Zhu, ZG | 1 |
| Dai, N; Si, JM; Wu, JG; Yu, HG; Yu, LL | 1 |
| Baybay, H; Berrady, R; Bono, W; El Hatimi, A; Gallouj, S; Khammar, Z; Lahlou, M; Lamchachti, L; Mernissi, FZ | 1 |
| Korbakis, D; Scorilas, A | 1 |
| DU, JP; Han, Y; Li, SJ; Wang, JH; Wang, ZH; Wu, ZT; Yang, XY; Zhai, LP | 1 |
| Bao, Y; Cao, JM; Li, GL; Li, JS; Liu, K; Wang, XL; Wu, B; Xu, J | 1 |
| Matsunaga, M; Miwa, K; Noguchi, T; Sasaki, Y | 1 |
| Cao, J; Fan, C; Li, G; Li, N; Liu, S; Xu, J; Zhang, C | 1 |
| Eitaki, M; Inanami, O; Meike, S; Yamamori, T; Yasui, H | 1 |
| Fujii, Y; Kihara, K; Komai, Y; Noguchi, N; Waseda, Y; Yano, A | 1 |
| Amato, B; Cardin, F; Lorenzetti, R; Martella, B; Militello, C; Terranova, C | 1 |
| Obuchi, W; Ohmine, K; Ohtsuki, S; Terasaki, T; Uchida, Y; Yamori, T | 1 |
| Fujii, T; Fujiwara, M; Jinno, S; Kobayashi, D; Kodera, Y; Nomoto, S; Ohashi, N; Shimokata, T; Takeda, S; Tanaka, C; Yamada, S | 1 |
| Fragoulis, EG; Korbakis, D; Scorilas, A | 1 |
| Berland, B; Cohen, C; Le Tortorec, S; Potier, P; Pozzo, A; Saint-Marc, O | 1 |
| Araki, H; Kato, T; Miwa, Y; Moriwaki, H; Nagaki, M; Naito, T; Uematsu, T; Yasuda, I | 1 |
| Fujii, M; Kanamori, N; Kasakura, Y; Kochi, M; Mochizuki, F; Takayama, T; Wakabayashi, K; Yamagata, M | 1 |
| Berkow, RL; Hilliard, LM; Watts, RG | 1 |
| Akiyama, H; Kunisaki, C; Matsuda, G; Nomura, M; Ono, H; Otsuka, Y; Shimada, H | 1 |
| Hamano, K; Hirohata, S; Inoue, H; Kawaguchi, K; Maeda, T; Matsumoto, I; Nakashima, T; Niki, T; Nishisaki, H; Okutani, T; Sashikata, T; Yasutake, K | 1 |
| Cai, GR; Jiao, LP; Li, PW | 1 |
| Bar Sela, G; Gaitini, D; Haim, N; Steiner, M; Tsalic, M | 1 |
| Liu, J; Tang, WJ; Yu, RC | 1 |
| Duan, P; Wang, ZM | 1 |
| Lee, HW; Lee, SJ; Lee, SS; Um, HD | 1 |
| Hosoya, Y; Kaneko, Y; Koinuma, K; Nagai, H; Saito, K; Yasuda, Y | 1 |
| Kamata, J; Kitoh, K; Kotake, Y; Koyanagi, N; Nagasu, T; Nakamura, K; Niijima, J; Okada, T; Sugumi, H; Taniguchi, T; Uenaka, T; Yamaguchi, A; Yoshimatsu, K; Yoshino, H | 1 |
| Chung, HC; Jang, WI; Jeung, HC; Kim, BS; Min, JS; Noh, SH; Rha, SY; Roh, JK; Shin, HJ; Sohn, JH | 1 |
| Baek, WK; Cho, JW; Jeong, YW; Kim, KS; Lee, JC; Oh, JY; Park, JC; Suh, MH; Suh, SI | 1 |
| Aparicio Urtasun, J; Gironés Sarrió, R; López-Tendero, P; Pérez-Fidalgo, JA; Segura Huerta, A | 1 |
| Becker, K; Böttcher, K; Busch, R; Fink, U; Höfler, H; Mueller, JD; Ott, K; Schulmacher, C; Siewert, JR | 1 |
| Bar-Sela, G; Gaitini, D; Haim, N; Steiner, M; Tsalic, M | 1 |
| Jiang, Q; Ju, AP; Xu, GH; Zhang, WM; Zheng, YT | 1 |
| Fujiki, H; Harada, S; Imura, K; Itoh, T; Kimura, T; Naito, K; Nomura, K; Sonoda, Y; Taniwaki, M; Ueda, Y; Yamagishi, H | 1 |
| Doi, K; Horiuchi, T; Nakamura, T; Okubo, Y; Shimada, K; Tanabe, S; Tanaka, K; Tanaka, S; Uchinami, M; Yoshida, M | 1 |
| Fujii, M; Kaiga, T; Kasakura, Y; Kobayashi, M; Kochi, M; Morishita, Y; Takahashi, T; Takayama, T | 1 |
| Barone, C; Basso, M; Brunetti, IM; Cassano, A; D'Ugo, D; Longo, R; Persiani, R; Picciocchi, A; Pozzo, C; Schinzari, G | 1 |
| Ebuchi, M; Hasegawa, K; Kato, K; Koide, A; Maruyama, M; Maruyama, S; Obu, M; Shinoura, H; Takashima, I | 1 |
| Barone, C; D'Ugo, D; La Torre, G; Persiani, R; Picciocchi, A; Pozzo, C; Rausei, S; Ricci, R; Sermoneta, D | 1 |
| Bandou, E; Kawamura, T; Matsuki, N; Sawa, T; Takahashi, S; Yonemura, Y | 1 |
| Fukushima, T; Hirose, Y; Itoh, H; Karasawa, H; Kawabata, H; Kojima, Y; Masaki, Y; Ogawa, N; Sawaki, T; Shimoyama, K; Sugai, S; Sutoh, H; Wano, Y | 1 |
| Du, J; Fan, D; Han, Q; Jin, X; Liu, C; Liu, N; Lu, Y; Pan, Y; Qiao, T; Shi, Y | 1 |
| Eimermacher, A; Flieger, D; Galle, PR; Geer, T; Gracien, E; Heike, M; Höhler, T; Junginger, T; Menges, M; Moehler, M; Siebler, J; Wein, A | 1 |
| Aoyagi, K; Imaizumi, T; Koufuji, K; Miyagi, M; Murakami, N; Shirouzu, K; Yano, S | 1 |
| Hirono, Y; Iida, A; Katayama, K; Murakami, M; Yamaguchi, A | 1 |
| Chen, HL; Liu, SQ; Lv, P; Yu, HG; Yu, JP | 1 |
| Abbey-Toby, A; Aparicio, T; Bouarioua, N; Chosidow, D; Karila Cohen, P; Mathieu, N; Soulé, JC; Stefanescu, C | 1 |
| Anai, H; Anegawa, G; Honda, M; Kai, T; Kaneko, S; Masuda, T; Nakamura, Y; Ohta, R; Saeki, H; Yokoyama, S | 1 |
| Biondi, A; Boccia, S; D'Ugo, D; Persiani, R; Rausei, S; Ricci, R; Vigorita, V | 1 |
| Fang, C; Song, MQ; Sun, Q; Wang, L; Zhu, JS; Zhu, L | 1 |
| Ge, W; Wu, YG; Xu, XM; Yu, HG | 1 |
| Cartenì, G; Catalano, G; Ciardiello, F; Colucci, G; De Vita, F; Di Martino, N; Galizia, G; Gebbia, V; Giuliani, F; Maiello, E; Manzione, L; Montemurro, F; Orditura, M; Romito, S | 1 |
| Koizumi, K; Kondo, M; Minauchi, K; Mukai, M; Odani, T; Takada, A | 1 |
| Chen, XM; Feng, JX; Wang, YJ; Zhang, X; Zhu, FS | 1 |
| Ge, W; Li, JH; Wu, YG; Xu, XM; Yuan, GJ; Zhou, ZY | 1 |
| Ai, YW; Cao, J; Chen, J; Deng, Q; Li, JH; Liu, F; Liu, J; Liu, S; Liu, SQ; Luo, HS; Qi, YL; Xu, XM; Yu, HG; Yu, JP; Yu, LL; Zhou, XD | 1 |
| Babić, DR; Jelić, SB; Jezdić, SD; Krivokapić, ZV; Micev, MT; Pesko, PM; Popov, IP | 1 |
| Du, R; Fan, D; Hong, L; Liu, J; Pan, Y; Sun, S; Xia, L; Zhang, D; Zhao, L | 1 |
| Demachi, H; Konishi, K; Kuroda, Y; Tsugawa, K; Tsuji, M; Yabushita, K | 1 |
| Gonda, T; Higuchi, T; Hirukawa, H; Hojo, I; Ishida, H; Mishima, Y; Nakajima, H | 1 |
| Böttcher, K; Busch, R; Dittler, HJ; Feussner, H; Fink, U; Helmberger, A; Schuhmacher, C; Siewert, JR; Stein, HJ | 1 |
| Fujimura, T; Fujita, H; Fushida, S; Hirono, Y; Itoh, H; Kaji, M; Kinami, S; Nakagawara, H; Nakai, M; Yonemura, Y | 1 |
| Cascinu, S; Catalano, G | 1 |
| Aizawa, K; Hatakeyama, K; Muto, I; Nishimaki, T; Suzuki, S; Suzuki, T; Tanaka, N; Tanaka, O; Yabusaki, H | 1 |
| Benson, AB; Clark, JL; Douglass, HO; Haller, DG; Küçük, O; Mansour, EG; Neuberg, DS; Pandya, KJ; Taylor, SG | 1 |
| Adenis, A | 1 |
| Fujita, T; Hirabayashi, T; Houya, Y; Kohno, S; Masaoka, N; Matai, K; Oda, Y; Toya, N | 1 |
| Kawai, K; Kawasaki, S; Maruyama, S; Misumi, T; Morokoshi, Y; Murakami, M; Nagai, K; Soda, M; Yamamoto, M; Yosizane, K | 1 |
| Comella, G; Comella, P; Frasci, G; Galizia, G; Iaffaioli, RV; Imbriani, A; Persico, G; Salzano, F | 1 |
| Horiuchi, Y; Ina, K; Iwase, H; Kaneko, H; Kuroiwa, A; Kusugami, K; Morise, K; Oka, Y; Shinoda, M; Suga, S | 1 |
| Chang, KJ; Chen, BR; Chen, YC; Cheng, AL; Lee, PH; Lee, WJ; Lin, JT; Wang, CH; Wang, TH; Yeh, KH | 1 |
| Higashida, T; Koishi, Y; Koyama, H; Masuyama, M; Miyata, K; Mugitani, T; Takeuchi, K; Tanaka, H; Taniguchi, H; Yamaguchi, T | 1 |
| Kawai, K; Kawasaki, S; Maruyama, S; Morokoshi, Y; Murakami, M; Nagai, K; Soda, M; Yamamoto, M; Yoshizane, K | 1 |
| Wakui, A | 1 |
| Chin, K; Hattori, T; Hayakawa, M; Maeda, H; Morise, K; Morooka, Y; Saito, H; Sugihara, M | 1 |
| Horichi, H; Kumaki, T; Matsuki, N; Shima, K; Tajima, H; Takeda, T | 1 |
| Desiderio, F; Fattori, PP; Gianni, L; Nicolini, M; Oliverio, G; Pasquini, E; Ravaioli, A; Scarpellini, M; Tononi, A | 1 |
| Kurimoto, H; Okamura, T; Ono, K; Sakata, Y; Uenishi, M | 1 |
| Borsellino, N; Cipolla, C; Florena, M; Gebbia, V; Latteri, M; Leo, P; Longo, A; Sciume, C; Testa, A; Valenza, R | 1 |
| Aisner, J; Belani, CP; Doyle, LA | 1 |
| Bajetta, E; Bochicchio, AM; Bozzetti, F; Comella, P; de Braud, F; Di Bartolomeo, M; Fagnani, D; Farina, G; Ferroni, C; Franchi, R | 1 |
| Akita, Y; Anzai, K; Arai, K; Ishii, M; Itoh, T; Kawada, T; Kawamura, M; Mitamura, K; Nishida, H; Onuki, M | 1 |
| Beijnen, JH; Boot, H; Dubbelman, R; Taal, BG; Teller, FG; ten Bokkel Huinink, WW | 2 |
| Cascinu, S; Catalano, G; Fedeli, A | 1 |
| Acimovic, LJ; Jeremic, B; Matovic, M | 1 |
| Ajani, JA; Dumas, P; Evans, D; Gray, C; Mayer, RJ; Ota, DM; Roh, M; Steele, GD; Sugarbaker, DJ; Vena, DA | 1 |
| Abe, Y; Ikeda, A; Miyamoto, K; Moriya, A; Yokoyama, N; Yokoyama, T | 1 |
| Chikamori, M; Genba, K; Ikubo, S; Kimura, I; Kiura, K; Matsumura, T; Matsuo, K; Ohnoshi, T; Tabata, M; Ueoka, H | 1 |
| Jibiki, M; Kusano, H; Matsuo, T; Miura, T; Miyashita, K; Nakagoe, T; Tomita, M | 1 |
| Itoh, A; Koyama, H; Miyata, K; Oguro, A; Okano, S; Sawai, K; Takeuchi, K; Tanaka, H; Taniguchi, H; Ueshima, Y | 1 |
| Akiyama, T; Kiriyama, M; Kita, I; Kosaka, T; Nakagawa, T; Nakano, Y; Saito, H; Takano, Y; Takashima, S; Tomita, F | 1 |
| Inada, T; Kano, Y; Ogata, Y; Suda, K | 1 |
| Harada, T; Jinnai, H; Ohe, T; Saegusa, S; Suzuki, Y; Ueno, N | 1 |
| Endo, Y; Hanasawa, K; Ishibashi, H; Kodama, M; Kurumi, Y; Sano, H; Shibata, J; Tani, T; Terata, N; Tsuji, K | 1 |
| Kato, M; Kinoshita, K; Matsui, H; Miyazaki, I; Sawa, T; Takano, Y; Tomita, F; Yonemura, Y; Yoshimitsu, S | 1 |
| Amadori, D; Amadori, M; Giunchi, DC; Innocenti, MP; Maltoni, R; Ridolfi, R | 1 |
| Fukuda, H; Hosokawa, K; Kondo, H; Ohtsu, A; Saito, D; Shimada, Y; Shirao, K; Yamao, T; Yoshida, S | 1 |
| Ben-Arieh, Y; Ben-Shahar, M; Epelbaum, R; Freidin, N; Haim, N; Leviov, M; Reshef, R | 1 |
| Angelsen, V; Norum, J | 1 |
| Cheong, SK; Kim, JS; Kim, YH; Lee, JD; Park, JS; Shin, SW | 1 |
| Chen, PM; Chiou, TJ; Fan, S; Hsieh, RK; Kung, SP; Tzeng, CH; Wei, CH | 1 |
| Wils, J | 2 |
| Belón, J; Blanco, E; Espinosa, E; Feliu, J; García-Alfonso, P; García-Girón, C; Garrido, P; Gómez-Navarro, J; González Barón, M; Ordónez, A; Zamora, P | 1 |
| Fujioka, S; Kato, K; Tomono, H | 1 |
| Abo, K; Hasegawa, H; Horita, K; Nakanishi, Y; Nakashima, T; Nishisaki, H; Oya, M; Yasutake, K; Yoshida, R | 1 |
| Fujiwara, T; Gochi, A; Hamada, M; Hizuta, A; Orita, K; Takahashi, K; Takakura, N; Tanaka, N | 1 |
| Ang, PT; Au, E; Koo, WH; Tan, EH | 1 |
| Fujii, K; Fukuda, T; Hoshino, T; Ishii, T; Komatsu, M; Masamune, O; Mikami, K; Ohshima, S; Ono, T | 1 |
| Hirono, T; Hirosawa, H; Izumi, R; Kadoya, N; Konishi, I; Ohta, N; Saito, K; Ueda, N; Yoshimitsu, Y | 1 |
| Belón, J; Blanco, E; Espinosa, E; Feliu, J; Garcia Alfonso, P; Garcia Girón, C; Garrido, P; González Barón, M; Jara, C; Ruiz, A; Vincent, JM; Zamora, P | 1 |
| Cowan, KH; Fukuda, M; Ikeda, K; Kohno, S; Matsuo, I; Nakano, R; Narasaki, F; Oka, M; Soda, H; Takatani, H; Terashi, K; Tomonaga, M | 1 |
| Behringer, D; Fetscher, S; Finke, J; Kanz, L; Lange, W; Lübbert, M; Mertelsmann, R | 1 |
| Ekström, K; Enander, LK; Glimelius, B; Graf, W; Haglund, U; Heuman, R; Hoffman, K; Linné, T; Sellström, H; Sjödén, PO; Svensson, C | 1 |
| Boardman, P; Braybrooke, JP; Ganesan, TS; Harris, AL; O'Byrne, KJ; Propper, DJ; Salisbury, AJ; Saunders, MP; Talbot, DC; Taylor, M | 1 |
| Akbulut, H; Cay, F; Demirkazik, A; Dinçol, D; Içli, F; Karaoguz, H | 1 |
| Hausamen, TU; Loeffler, TM | 1 |
| Athanassiou, A; Dimitriades, M; Kostopoulou, M; Mylonakis, A; Papadopoulou, M; Pectasides, D; Triantafillis, D; Varthalitis, J | 1 |
| Bayle, C; Corti, C; Cosset, JM; Girinsky, T; Hayat, M; Nasr, F; Ribrag, V; Rougier, P; Theodore, C | 1 |
| Harstrick, A; Kasimir-Bauer, S; Stahl, M | 1 |
| Camoriano, JK; Fitch, TR; Frytak, S; Rajkumar, SV; Rubin, J | 1 |
| Belón, J; de Castro, J; Espinosa, E; Feliu, J; García Alfonso, P; García Girón, C; Garrido, P; González Barón, M; Lomas, M; Ordóñez, A; Zamora, P | 1 |
| Bertz, H; Brugger, W; Fetscher, S; Kanz, L; Krieger, G; Lange, W; Mertelsmann, R | 1 |
| Etoh, Y; Imamura, H; Kamio, T; Nogami, T; Nomura, H; Saeki, T; Sakai, K; Suko, H; Suko, S; Tokunaga, H | 1 |
| Sakata, Y; Tsushima, K | 1 |
| Araki, S; Asakura, R; Hojo, K; Itoh, A; Kawahara, M; Konishi, T; Nouchi, T; Takeda, Y; Teruya, M | 1 |
| Astone, A; Barone, C; Cassano, A; Colloca, G; Corsi, DC; Fontana, T; Landriscina, M; Noviello, MR; Pozzo, C | 1 |
| Bajetta, E; Bochicchio, AM; Buzzoni, R; Carnaghi, C; Comella, G; Di Bartolomeo, M; Gebbia, V; Ianniello, G; Maiorino, L; Mariani, L; Pinotti, G; Schieppati, G | 1 |
| Kamiyama, H; Kawashima, K; Koike, N; Morishita, Y; Ogawa, T; Ohwada, S; Sato, Y; Takeyoshi, I | 1 |
| Chen, CL; Chen, YC; Cheng, AL; Lee, PH; Lee, WJ; Lin, JT; Shun, CT; Yeh, KH | 1 |
| Chan, WK; Chao, Y; Chen, KY; Chen, SY; Chi, KH; Lee, SD; Lo, SS; Lui, WY; Wu, CW; Yen, SH | 1 |
| Chen, PM; Chiou, TJ; Fan, FS; Hsieh, RK; Liu, JH; Tung, SL; Wang, WS; Yen, CC | 1 |
| Ajani, JA | 1 |
| Brodowicz, T; Fiebiger, WC; Hejna, MH; Kornek, GV; Miholic, J; Raderer, M; Scheithauer, W; Valencak, JB; Weinlaender, G | 1 |
| Bjarnason, GA; Cripps, C; Dulude, H; Fine, S; Franssen, E; Germond, CJ; Goel, R; Kerr, I; Maroun, JA; Moore, MJ; Oza, AM; Skillings, JR | 1 |
| Akbulut, H; Aykan, F; Celik, I; Demirkazik, A; Firat, D; Içli, F; Ozet, A; Ozgüroğlu, M; Taş, F; Uner, A | 1 |
| Armand, JP; Couteau, C | 1 |
| Asano, K; Futagami, F; Kawahara, E; Matsumura, A; Ohhori, I; Sasaki, M | 1 |
| Aizawa, K; Fukuda, M; Ikeda, K; Kimura, Y; Kohno, S; Mizuta, Y; Nakamura, T; Noguchi, Y; Oka, M; Soda, H; Terashi, K; Tsuruo, T | 1 |
| Alberto, P; Bacchi, M; Borner, MM; Castiglione, M; Herrmann, R; Honegger, HP; Lange, J; Morant, R; Obrist, R; Roth, AD | 1 |
| Adamo, V; Altavilla, G; Ferraro, G; Laudani, A; Maisano, R; Pergolizzi, S; Scimone, A; Zanghì, M | 1 |
| Bando, E; Fujimura, T; Fujita, H; Fushida, S; Michiwa, Y; Miwa, K; Nishimura, G; Oyama, K; Taniguchi, K; Yonemura, Y | 1 |
| Ajani, J; Dumas, P; Partyka, S | 1 |
| Anderson, NR; Bern, MM; Coco, FV; Dow, E; Lokich, JJ; Oliynyk, P; Sonneborn, H | 1 |
| Baek, HJ; Im, YH; Jung, SH; Kang, YK; Kim, BS; Kim, CM; Kim, TY; Kim, YC; Kim, YJ; Park, JH; Ryoo, BY; Shim, YM; Zo, JI | 1 |
| Borsellino, N; Colucci, G; Fortunato, S; Gebbia, N; Gebbia, V; Giuliani, F; Lelli, G; Lopez, M; Maiello, E; Testa, A | 1 |
| Hirose, K; Iida, A; Katayama, K; Kusaka, Y; Nakagawara, G; Umeda, S; Yamaguchi, A | 1 |
| Inoue, H; Kim, R; Ohi, Y; Toge, T | 1 |
| Asano, M; Higashi, S; Hosono, Y; Kane, T; Kato, C; Matsumoto, K; Sakoda, M; Sakumoto, H; Sumiyoshi, K; Takahahsi, T; Takahashi, M; Yamamoto, A | 1 |
| Ishihara, S; Kato, Y; Kitagawa, T; Nakajima, T; Ninomiya, Y; Yanagisawa, A | 1 |
| Asbury, R; Dutcher, JP; Haller, DG; Novik, Y; Ryan, LM; Schutt, A | 1 |
| Ajisaka, H; Bando, E; Fujimura, T; Fushida, S; Hayashi, T; Minatoya, T; Miwa, K; Nishimura, G; Taniguchi, K; Yonemura, Y | 1 |
| Ajani, JA; Takiuchi, H | 1 |
| Chang, FY; Chao, Y; Chi, KH; Hung, HC; King, KL; Li, CP; Teng, HC; Yen, SH | 1 |
| Baron, B; Bleiberg, H; Bodenstein, H; Couvreur, ML; Ducreux, MP; Lacave, AJ; Nordlinger, B; Paillot, B; Piedbois, P; Planker, M; Rougier, P; Santos, JG; Schmoll, HJ; Van Cutsem, E; Vanhoefer, U; Wilke, H; Wils, JA | 1 |
| Ajani, JA; Yao, JC | 1 |
| Fabian, A | 1 |
| Fujii, M; Kochi, M; Mochizuki, F | 1 |
| Balaguer-Martínez, JV; Castillo-Pallarés, FJ; Ferrer Albiach, C; Pallardó-Calatayud, J; Romero-de-Avila, C; Ruiz Hernández, G | 1 |
| Berner, A; Berner, J; Pasz, S; Piekarski, J; Tenderenda, M | 1 |
| Kołodziejczyk, P; Kulig, J; Popiela, T | 1 |
| Dempke, W; Kellner, O; Schmoll, HJ; von Poblozki, A; Wolf, HH | 1 |
| Becker, K; Busch, R; Fink, U; Höfler, H; Mueller, J; Siewert, JR | 1 |
| Becker, K; Busch, R; Dittler, HJ; Fink, U; Mueller, J; Schuhmacher, CP; Siewert, JR | 1 |
| Herman, ZS; Machalski, M; Scieszka, M; Zielinski, M | 1 |
| Eguchi, T; Fujii, M; Imai, S; Kasakura, Y; Kobayashi, M; Kochi, M; Mochizuki, F | 1 |
| Gochi, A; Isozaki, H; Matsuno, T; Naomoto, Y; Shigemitsu, K; Tanaka, N | 1 |
| Earashi, M; Kobayashi, H; Matsuki, N; Michiwa, Y | 1 |
| Eguchi, T; Fujii, M; Kaiga, T; Kanamori, N; Kasakura, Y; Kobayashi, M; Kochi, M; Mochizuki, F; Tsuneda, Y; Wakabayashi, K | 1 |
| Kolodziejcyk, P; Kulig, J; Popiela, T | 1 |
| Cruz-Caudillo, JC; Liu, Z; Mira, JL | 1 |
| Basso, B; Boiocchi, M; Colussi, AM; Corona, G; Robieux, I; Sorio, R; Toffoli, G | 1 |
| Hinterleitner, T; Kerbl, R; Schwinger, W; Smolle Juettner, FM; Urban, C; Zotter, H | 1 |
| Wen, Z; Xiong, X; Zhu, Z | 1 |
| Feng, J; Pang, L; Wang, X | 1 |
| Aiba, K; Akaza, H; Blackledge, G; Boku, N; Ikeda, T; Isonishi, S; Kato, M; Kawai, K; Mikami, O; Ohashi, Y; Saeki, T; Saijo, N; Sone, S; Stribling, D; Tsukagoshi, S; Tsuruo, T | 1 |
| Aotake, T; Horiuchi, T; Matsumura, M; Tabo, T; Tanaka, K; Tanigawa, N; Uchinami, M; Yokomachi, J | 1 |
| Clemm, C; Draczynski, T; Linde, K; Melchart, D; Saller, R; Wagner, H; Weber, B; Weidenhammer, W; Worku, F | 1 |
| Chang, JY; Chao, Y; Chen, JD; Chen, LT; Lan, C; Li, AF; Lin, WC; Liu, JM; Liu, TS; Shiah, HS; Whang-Peng, J; Wu, CW; Wu, HW | 1 |
| Rudi, J; Schulze-Bergkamen, H; Stremmel, W; Teufel, A; Zuna, I | 1 |
| Cai, JH; Huang, ZW; Liu, S; Su, WJ; Wu, Q; Ye, XF | 1 |
| Hwang, PH; Lee, DY; Oh, Y; Yi, HK | 1 |
| Emile, JF; Germann, N; Goldwasser, F; Gross-Goupil, M; Misset, JL; Reynes, M; Wasserman, E | 1 |
| Kowalski, P; Lage, H; Scheffer, GL; Stein, U | 1 |
| Hartmann, D; Obrecht, JP; Stalder, GA | 1 |
| Anton, A; Aranda, E; Camps, C; Cervantes, A; Cruz Hernández, JJ; Díaz-Rubio, E; Dominguez, S; Dorta, J; Jimeno, J; Massuti, B | 1 |
| Saini, A; Waxman, J | 1 |
| Fushida, S; Kaji, M; Kosaka, T; Matsumoto, H; Muraoka, K; Nakai, M; Segawa, M; Takano, Y; Tsugawa, K; Yonemura, Y | 1 |
| Fukushima, W; Hirosawa, H; Kadoya, N; Konishi, K; Kuroda, Y; Sahara, H; Saitoh, F; Taniya, T; Tsuji, M; Yabushita, K | 1 |
| Chiba, M; Hayashi, K; Inaba, Y; Kudo, K; Otsuka, S; Watabe, S | 1 |
| Kimura, H; Kinoshita, K; Kosaka, T; Miwa, K; Miyazaki, I; Ninomiya, I; Ohyama, S; Tanaka, M; Tsugawa, K; Yonemura, Y | 1 |
| Ajani, JA; Dumas, P | 1 |
| Havlin, KA; Macdonald, JS | 1 |
| Hasegawa, E; Hirakawa, S; Momose, K; Ohmura, G; Watanabe, H | 1 |
| O'Connell, MJ | 1 |
| Gonin, R; Lerner, A; Mayer, RJ; Steele, GD | 1 |
| Atiq, OT; Brennan, M; Chapman, D; Ginn, D; Heelan, R; Kelsen, D; Lightdale, C; Niedzwiecki, D; Saltz, L; Vinciguerra, V | 1 |
| Hirose, T; Koh, Y; Nakamura, T; Nakayoshi, A; Namatame, K; Ookubo, M; Sasaki, E; Shimada, K | 1 |
| Bandou, H; Kobayashi, T; Mura, T; Nomura, T; Watanabe, K | 1 |
| Hamano, K; Ihara, H; Imai, S; Kirita, T; Kon, M; Nishiyama, T; Ohchi, T | 1 |
| Achterrath, W; Fink, U; Gerlings, H; Lenaz, L; Mayer, HJ; Meyer, J; Preusser, P; Siewert, JR; Stahl, M; Wilke, H | 1 |
| Miyazaki, I; Ohyama, S; Sasaki, T; Tanaka, M; Tsugawa, K; Yonemura, Y | 1 |
| Taguchi, T | 1 |
| Ogawa, M | 1 |
| Achterrath, W; Harstrick, A; Meyer, HJ; Preusser, P; Schmoll, HJ; Seeber, S; Stahl, M; Wilke, H | 1 |
| Astone, A; Barone, C; Cassano, A; Fontana, T; Garufi, C; Grieco, A; Noviello, MR; Pacelli, F; Ricevuto, E | 1 |
| Chaitchik, S; Inbar, M; Merimsky, O | 1 |
| Endo, Y; Kinoshita, K; Miyazaki, I; Ninomiya, I; Ohyama, S; Sasaki, T; Tanaka, M; Yonemura, Y | 1 |
| Bresciani, CJ; Gama-Rodrigues, J; Gansl, RC; Katz, A; Pinotti, HW; Simon, SD; Waitzberg, D | 1 |
| Bernacer, B; Candel, MT; Garcia, J; Jimeno, J; Villar-Grimalt, A | 1 |
| Haim, N; Robinson, E | 1 |
| Itoh, A; Oguro, A; Okano, S; Sawai, K; Takahashi, T; Takeuchi, K; Taniguchi, H; Tsukuda, N; Ueshima, Y | 1 |
| Ishihara, S; Mizuno, S; Nakajima, T; Nishi, M; Ohashi, Y; Ohta, K; Okumura, S; Toyoda, S; Tsuchiya, S | 1 |
| Ajani, JA; Ames, FC; Boddie, A; Hohn, D; Jackson, DE; Jessup, JM; Levin, B; McBride, C; Ota, DM; Roh, M | 1 |
| Endo, Y; Kimura, H; Kinoshita, K; Miyazaki, I; Ninomiya, I; Ohyama, S; Sasaki, T; Tanaka, M; Tugawa, K; Yonemura, Y | 1 |
| Niitsu, Y; Saito, K; Sato, M; Takagane, A; Terashima, M; Yokkaichi, H | 1 |
| Hasegawa, Y; Honnma, S; Nakashima, Y; Takanashi, K; Yajima, K | 1 |
| Airo, I; Helve, O; Hiltunen, KM; Mattila, J | 1 |
| Fujita, F; Fujita, M; Inaba, H; Okuyama, Y; Sugimoto, T; Taguchi, T | 1 |
| Bagshawe, KD; Begent, RH; Ledermann, JA; Newlands, ES; Philip, PA; Rustin, GJ | 1 |
| Kido, Y; Mori, T; Ogawa, M; Ohashi, I; Sakurai, M; Shiozaki, H; Tahara, H | 1 |
| Ajani, JA; Jackson, DE; Ota, DM | 1 |
| Kido, Y; Kobayashi, K; Matsuura, N; Miyata, M; Murata, A; Nishijima, J; Ogawa, M; Shiozaki, H; Tahara, H; Tsujinaka, T | 1 |
| Endo, Y; Kimura, H; Kosaka, T; Miyazaki, I; Ohyama, S; Sasaki, T; Tanaka, M; Tugawa, K; Yonemura, Y | 1 |
| Kato, M; Kinoshita, K; Miwa, K; Ohyama, S; Sawa, T; Segawa, M; Takano, Y; Tomita, F; Yonemura, Y; Yoshimitsu, S | 1 |
| Chen, YZ; Jia, ZP; Li, JX; Liang, ZD; Tian, X; Wang, YG; Zhang, PY | 1 |
| Imamura, Y; Masuda, T; Matsushita, K; Ohno, S; Oya, M; Tokisue, M; Yasutake, K; Yoshimura, Y | 2 |
| Imamura, Y; Masuda, T; Matsushita, K; Ono, S; Oya, M; Tokisue, M; Yasutake, K; Yoshimura, Y | 1 |
| Izumi, R; Kobayashi, K; Matsui, O; Miyazaki, I; Shimizu, K; Watanabe, T | 1 |
| Edler, L; Flechtner, H; Harjung, H; Kabelitz, K; Manegold, C; Queisser, W; Räth, U; Schlag, P; Selbach, J; Trux, FA | 1 |
| Pizzillo, MF; Salva, KM; Schwartz, EL; Sparano, JA; Wadler, S; Wiernik, PH | 1 |
| Hurukawa, H; Iwanaga, T; Numata, N; Ohshiba, S; Ohta, J; Ohtani, T; Okazima, K; Orino, M; Taguchi, T; Yamada, S | 1 |
| Fujimura, T; Hasegawa, K; Kato, M; Kinoshita, K; Miyata, T; Ohyama, S; Sawa, T; Takekawa, S; Ueda, N; Watanabe, T | 1 |
| Achterrath, W; Fink, U; Geerlings, H; Lenaz, L; Meyer, HJ; Meyer, J; Preusser, P; Siewert, JR; Stahl, M; Wilke, H | 1 |
| Elliott, TE; Gerstner, JB; Hahn, RG; Mailliard, JA; Moertel, CG; Tschetter, LK; Wieand, HS | 1 |
| Sparano, JA; Wiernik, PH | 1 |
| Franklin, H; Rodenhuis, S; Taal, BG; ten Bokkel Huinink, WW | 1 |
| Asano, T; Gunji, Y; Hori, S; Isono, K; Koide, Y; Nabeya, Y; Ochiai, T; Ozaki, M; Shu, S; Suzuki, T | 1 |
| Achterrath, W; Fink, U; Lenaz, L; Link, H; Lucke, B; Meyer, HJ; Preusser, P; Schober, C; Stahl, M; Wilke, H | 1 |
| Chung, HC; Kim, BS; Lee, JT; Lee, KB; Lee, SI; Min, JS; Park, YJ; Roh, JK | 1 |
| Daidoh, T; Itoh, A; Oguro, A; Okano, S; Ono, K; Sawai, K; Shioaki, Y; Taniguchi, H; Tukuda, N; Yamaguchi, T | 1 |
| Akatsuka, Y; Ando, T; Hayakawa, M; Kokubu, K; Kuwahara, Y; Morise, K; Sakai, T; Sato, Y; Tahara, H; Thin, K | 1 |
| Imamura, Y; Matsusita, K; Okutani, T; Ono, S; Oya, M; Tokisue, M; Yasutake, K; Yoshimura, Y | 1 |
| Andoh, T; Hayashi, H; Kiyama, T; Miyamoto, M; Mizutani, T; Nishi, K; Nomura, T; Onda, M; Tokunaga, A; Umehara, M | 1 |
| Achterrath, W; Buente, H; Fink, U; Heinicke, A; Lenaz, L; Meyer, HJ; Meyer, J; Preusser, P; Wilke, H | 1 |
| Effenberger, T; Henne-Bruns, D; Kremer, B; Weh, HJ | 1 |
| Achterrath, W; Fink, U; Gunzer, U; Knipp, H; Lenaz, L; Meyer, HJ; Meyer, J; Preusser, P; Siewert, JR; Wilke, H | 1 |
| Aikou, T; Hokita, S; Maenohara, S; Shimazu, H; Takao, S; Tokushige, M | 1 |
| Kanbayashi, J; Kido, Y; Kobayashi, K; Miyamoto, T; Miyata, M; Murata, A; Ogawa, M; Shiozaki, H; Tahara, H; Tsujinaka, T | 1 |
| Aoyagi, H; Fujii, T; Izuo, M; Miyamoto, Y; Ohwada, S; Takeshita, M; Tanahasi, Y; Uchida, O | 1 |
| Creagan, ET; Kovach, JS; Richardson, RL | 1 |
| Hayakawa, M; Hayashi, N; Kaneshiro, K; Morise, K; Oka, Y; Suga, S; Suzuki, T; Tsunekawa, H; Umemura, K; Yoshida, H | 1 |
| Hayakawa, M; Morise, K; Oka, Y; Saito, H | 1 |
| Hamada, H; Kurooka, K; Mori, N; Nakajima, I; Nakamura, T; Nakamura, Y; Tanaka, A; Yasutomi, M; Yoshinobu, H | 1 |
| Achterrath, W; Fink, U; Meyer, HJ; Meyer, J; Neuhaus, P; Preusser, P; van de Loo, J; Wilke, H | 1 |
| Fujii, H; Iwai, M; Kashiwadani, M; Maekawa, T; Miyoshi, M; Suyama, Y; Urata, Y | 1 |
| Buckner, J; Einzig, A; Heelan, R; Kelsen, DP; Magill, G; Vinciguerra, V | 1 |
| Biasioli, R; Lombardi, F; Riundi, R; Scanni, A; Tomirotti, M | 1 |
21 review(s) available for etoposide and Cancer of Stomach
| Article | Year |
|---|---|
A comparison of neoadjuvant therapies for gastroesophageal and gastric cancer on tumour resection rate: A network meta-analysis.
Topics: Anthracyclines; Etoposide; Humans; Neoadjuvant Therapy; Network Meta-Analysis; Platinum Compounds; Pyrimidines; Quality of Life; Randomized Controlled Trials as Topic; Stomach Neoplasms; Taxoids | 2022 |
Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Intestinal Neoplasms; Irinotecan; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Stomach Neoplasms | 2019 |
[PRIMARY SMALL CELL NEUROENDOCRINE CARCINOMA OF THE URETER].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Gastrectomy; Humans; Laparoscopy; Male; Neoplasms, Multiple Primary; Nephroureterectomy; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Ureteral Neoplasms; Urologic Surgical Procedures, Male | 2018 |
[Clinical analysis of 17 cases of gastric small cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Etoposide; Female; Follow-Up Studies; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplastic Cells, Circulating; Retrospective Studies; Stomach Neoplasms; Survival Rate | 2013 |
Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cell Proliferation; Etoposide; Humans; Intestinal Neoplasms; Intestine, Small; Ki-67 Antigen; Neoplasm Grading; Pancreatic Neoplasms; Platinum Compounds; Prognosis; Stomach Neoplasms | 2016 |
[A case of alpha-fetoprotein-producing gastric cancer with hepatic metastasis successfully treated with combination chemotherapy].
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Stomach Neoplasms | 2008 |
Unusual case of small cell gastric carcinoma: case report and literature review.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Small Cell; Chromogranins; Diabetes Mellitus, Type 2; Endoscopy; Etoposide; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Prognosis; Stomach Neoplasms; Synaptophysin; Tretoquinol | 2011 |
[ALK-negative primary gastric anaplastic large cell lymphoma].
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Blood Stem Cell Transplantation; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Remission Induction; Salvage Therapy; Stomach Neoplasms; Transplantation, Autologous | 2007 |
[Chemotherapy of scirrhous gastric cancer].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Humans; Interferon alpha-2; Interferon-alpha; Leucovorin; Levoleucovorin; Mitomycin; Nimustine; Recombinant Proteins; Stomach Neoplasms; Tegafur; Uracil | 1994 |
Etoposide: current status and future perspectives in the management of malignant neoplasms.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Etoposide; Germinoma; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Neoplasms; Sarcoma, Kaposi; Stomach Neoplasms | 1994 |
The treatment of advanced gastric cancer.
Topics: Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Gastrectomy; Humans; Leucovorin; Methotrexate; Mitomycins; Randomized Controlled Trials as Topic; Stomach Neoplasms | 1996 |
[Treatment of recurrent gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Humans; Immunologic Factors; Irinotecan; Liver Neoplasms; Lymphatic Metastasis; Methotrexate; Mitomycin; Neoplastic Cells, Circulating; Peritoneal Neoplasms; Stomach Neoplasms | 1998 |
[Chemotherapy of gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Humans; Immunologic Factors; Irinotecan; Methotrexate; Stomach Neoplasms | 1998 |
Chemotherapy for gastric carcinoma: new and old options.
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Capecitabine; Deoxycytidine; Docetaxel; Drug Combinations; Enzyme Inhibitors; Etoposide; Fluorouracil; Humans; Infusions, Intravenous; Irinotecan; Oxonic Acid; Paclitaxel; Pyridines; Randomized Controlled Trials as Topic; Stomach Neoplasms; Taxoids; Tegafur; Uracil | 1998 |
[Irinotecan-containing combinations in solid tumors, except colonic carcinomas].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Diarrhea; Docetaxel; Enzyme Inhibitors; Etoposide; Female; Genital Neoplasms, Female; Humans; Irinotecan; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasm Proteins; Neoplasms; Neutropenia; Paclitaxel; Stomach Neoplasms; Taxoids; Topoisomerase I Inhibitors; Treatment Outcome | 1998 |
Recent developments in oral chemotherapy options for gastric carcinoma.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Drug Combinations; Etoposide; Humans; Stomach Neoplasms; Tegafur; Uracil | 1999 |
Preoperative therapy for local-regional gastric cancer: rationale and review of trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Doxorubicin; Etoposide; Fluorouracil; Humans; Methotrexate; Mitomycin; Preoperative Care; Stomach Neoplasms; Tegafur; Uracil | 2000 |
Chemotherapy of metastatic gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Fluorouracil; Humans; Leucovorin; Methotrexate; Randomized Controlled Trials as Topic; Stomach Neoplasms | 2000 |
[Significance of neoadjuvant chemotherapy for gastric cancer].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Fluorouracil; Humans; Leucovorin; Neoadjuvant Therapy; Preoperative Care; Stomach Neoplasms; Survival Rate | 2000 |
Etoposide in gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Etoposide; Humans; Stomach Neoplasms | 1992 |
Current strategies in the management of locoregional and metastatic gastric carcinoma.
Topics: Antineoplastic Agents; Combined Modality Therapy; Etoposide; Humans; Stomach Neoplasms | 1991 |
89 trial(s) available for etoposide and Cancer of Stomach
| Article | Year |
|---|---|
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carcinoma, Neuroendocrine; Etoposide; Female; Fluorouracil; Humans; Intestinal Neoplasms; Irinotecan; Leucovorin; Male; Neoplasm Metastasis; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Oxaliplatin; Pancreatic Neoplasms; Platinum Compounds; Progression-Free Survival; Prospective Studies; Quality of Life; Stomach Neoplasms; Survival Rate; Treatment Outcome | 2021 |
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Female; Gastrectomy; Glucuronates; Humans; Male; Middle Aged; Neoplasm Staging; Perioperative Care; Stomach Neoplasms; Survival Rate; Time Factors; Treatment Outcome | 2008 |
A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Carcinoma, Squamous Cell; Cardia; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclooxygenase 2 Inhibitors; Esophageal Neoplasms; Esophagectomy; Etoposide; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Radiotherapy, Adjuvant; Stomach Neoplasms; Survival Analysis | 2009 |
[Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Levoleucovorin; Male; Middle Aged; Nausea; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Stomach Neoplasms; Survival Rate; Thrombocytopenia; Vomiting | 2009 |
A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Docetaxel; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids | 2010 |
Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Gastrectomy; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Analysis | 2010 |
Retrospective analysis of 56 patients with advanced gastric cancer treated with combination of intravenous and intra-arterial intensified neoadjuvant chemotherapy.
Topics: Adult; Aged; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Retrospective Studies; Stomach Neoplasms | 2012 |
Combination chemotherapy comprising 5-fluorouracil, leucovorin, etoposide, and cis-diamminedichloroplatinum for the treatment of advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Stomach Neoplasms; Survival Rate | 2002 |
[Effectiveness of continuous hyperthermic peritoneal perfusion for the peritoneal dissemination of gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Etoposide; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Mitomycin; Peritoneal Neoplasms; Prognosis; Regression Analysis; Stomach Neoplasms | 2002 |
[Clinical observation of music therapy combined with anti-tumor drugs in treating 116 cases of tumor patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drugs, Chinese Herbal; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Music Therapy; Phytotherapy; Stomach Neoplasms | 2001 |
Etoposide, doxorubicin and cisplatin alternating with 5-fluorouracil, doxorubicin and high-dose methotrexate in patients with advanced adenocarcinoma of the stomach or the gastroesophageal junction.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Stomach Neoplasms; Treatment Outcome | 2002 |
[Influence of combined therapy of guben yiliu III, moxibustion and chemotherapy on immune function and blood coagulation mechanism in patients with mid-late stage malignant tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drugs, Chinese Herbal; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphocyte Count; Male; Mitomycin; Moxibustion; Phytotherapy; Stomach Neoplasms; T-Lymphocyte Subsets | 2002 |
[Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of chemotherapy in patients of malignant tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Astragalus propinquus; CD4-CD8 Ratio; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Drugs, Chinese Herbal; Etoposide; Female; Fluorouracil; Humans; Immunoglobulin G; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Phytotherapy; Stomach Neoplasms | 2002 |
Infusional fluorouracil, etoposide, and cisplatin (FEP) in advanced and relapsed gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Stomach Neoplasms; Survival Analysis | 2003 |
Paclitaxel, carboplatin, and oral etoposide in advanced gastric adenocarcinoma: association with severe myelotoxicity.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Etoposide; Female; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Stomach Neoplasms; Treatment Failure | 2003 |
[Clinical results of advanced gastric cancer patients treated with oxaliplatin-containing regimen].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Survival Rate; Treatment Outcome | 2003 |
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Glucuronates; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Pilot Projects; Stomach Neoplasms; Survival Analysis; Time Factors; Treatment Outcome | 2004 |
Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Esophagogastric Junction; Etoposide; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Levoleucovorin; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 2005 |
[Immunoregulation and short-term therapeutic effects of super-selective intra-arterial chemotherapy combined with traditional Chinese drugs on gastric cancer patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Synergism; Drug Therapy, Combination; Drugs, Chinese Herbal; Epirubicin; Etoposide; Female; Humans; Injections, Intra-Arterial; Interferon-gamma; Interleukin-2; Male; Middle Aged; Phytotherapy; Stomach Neoplasms; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2006 |
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Stomach Neoplasms | 2007 |
Bimonthly 24 h infusion of high-dose 5-fluorouracil vs EAP regimen in patients with advanced gastric cancer. A randomized phase II study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Prospective Studies; Stomach Neoplasms | 2008 |
Preoperative chemotherapy for stage III-IV gastric carcinoma: feasibility, response and outcome after complete resection.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Multivariate Analysis; Preoperative Care; Prognosis; Prospective Studies; Stomach Neoplasms; Time Factors; Treatment Outcome | 1995 |
Escalating dose of tegafur combined with oral etoposide in metastatic gastric carcinoma.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Tegafur | 1995 |
Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Remission Induction; Stomach Neoplasms; Survival Analysis | 1995 |
[Effect of intraperitoneal chemotherapy with implantable reservoir against unresectable gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Stomach Neoplasms | 1995 |
Intraperitoneal adjuvant immunochemotherapy in operable gastric cancer with serosal involvement.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Immunotherapy; Injections, Intraperitoneal; Interferon alpha-2; Interferon-alpha; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Recombinant Proteins; Risk; Stomach Neoplasms; Survival Analysis | 1994 |
[Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Research group of gastric cancer chemotherapy].
Topics: Adenocarcinoma; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Proportional Hazards Models; Stomach Neoplasms; Survival Rate; Tegafur; Uracil; Vomiting | 1995 |
[Recurrence and survival rate of advanced gastric cancer after preoperative EAP-II intra-arterial infusion therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Humans; Infusions, Intra-Arterial; Neoplasm Metastasis; Neoplasm Recurrence, Local; Preoperative Care; Stomach Neoplasms; Survival Rate | 1994 |
[The effect of intraperitoneal and intra-aortic chemotherapy for unresectable gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms | 1994 |
Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 1994 |
Etoposide, doxorubicin and cisplatin (EAP regimen) in advanced gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Stomach Neoplasms | 1994 |
Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms | 1994 |
Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Hematologic Diseases; Humans; Male; Middle Aged; Prognosis; Stomach Neoplasms | 1994 |
[Evaluation of combination chemotherapy for advanced gastric carcinoma as a neoadjuvant chemotherapy with CDDP, MMC, etoposide and 5'-DFUR].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Floxuridine; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Stomach Neoplasms | 1994 |
Etoposide, leucovorin, 5-fluorouracil (ELF) combination chemotherapy for advanced gastric cancer: experience with two treatment schedules incorporating intravenous or oral etoposide.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Injections, Intravenous; Leucovorin; Male; Middle Aged; Pilot Projects; Stomach Neoplasms | 1994 |
Etoposide, leucovorin, 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: a pilot study.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Fluorouracil; Humans; Interferon alpha-2; Interferon-alpha; Leucovorin; Levoleucovorin; Male; Pilot Projects; Recombinant Proteins; Stomach Neoplasms | 1994 |
Bioavailability of oral etoposide in gastric cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Etoposide; Fluorouracil; Gastrectomy; Humans; Leucovorin; Levoleucovorin; Male; Middle Aged; Stomach Neoplasms | 1994 |
Carboplatin and etoposide in patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Middle Aged; Stomach Neoplasms | 1993 |
An early phase II study of etoposide (VP-16) in advanced gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Alopecia; Anemia; Antineoplastic Agents, Phytogenic; Carcinoma, Signet Ring Cell; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Stomach Neoplasms | 1996 |
Intermediate and high-grade gastric non-Hodgkin's lymphoma: a prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gastrointestinal Hemorrhage; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Radiotherapy, Adjuvant; Stomach Neoplasms; Vincristine | 1995 |
Chemotherapy in gastric cancer: an economic evaluation of the FAM (5-fluorouracil, adriamycin, mitomycin C) versus ELF (etoposide, leucovorin, 5-fluorouracil) regimens.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Levoleucovorin; Male; Middle Aged; Mitomycin; Stomach Neoplasms | 1995 |
Phase II trial of Oral UFT and leucovorin in advanced gastric carcinoma.
Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Diarrhea; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Male; Middle Aged; Remission Induction; Stomach Neoplasms; Stomatitis; Survival Rate; Tegafur; Vomiting | 1996 |
Treatment of advanced gastric cancer with a modified regimen of etoposide/leucovorin/5-fluorouracil.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Stomach Neoplasms | 1996 |
Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Anemia; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Diarrhea; Drug Administration Schedule; Etoposide; Fluorouracil; Humans; Injections, Intravenous; Leucovorin; Middle Aged; Nausea; Remission Induction; Stomach Neoplasms; Survival Rate; Tegafur; Vomiting | 1996 |
A phase II trial of etoposide, leucovorin and 5-fluorouracil (ELF) in patients with advanced gastric cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Fluorouracil; Hematologic Diseases; Humans; Leucovorin; Levoleucovorin; Male; Middle Aged; Remission Induction; Stomach Neoplasms; Survival Rate | 1996 |
Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Etoposide; Head and Neck Neoplasms; Humans; Leucovorin; Lung Neoplasms; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1997 |
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Levoleucovorin; Male; Middle Aged; Quality of Life; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 1997 |
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Esophageal Neoplasms; Etoposide; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Treatment Outcome | 1997 |
Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Analysis; Vomiting | 1997 |
High-dose infusional 5-fluorouracil combination therapy of metastatic gastric and colorectal cancer.
Topics: Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dose-Response Relationship, Drug; Etoposide; Female; Fluorouracil; Humans; Infusions, Intravenous; Interferon-alpha; Leucovorin; Male; Middle Aged; Stomach Neoplasms; Survival Rate; Treatment Outcome | 1996 |
Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cause of Death; Cisplatin; Clinical Trials, Phase II as Topic; Cochlea; Digestive System Neoplasms; Drug Administration Schedule; Drug Synergism; Esophageal Neoplasms; Etoposide; Evaluation Studies as Topic; Female; Humans; Kidney; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Remission Induction; Sepsis; Stomach Neoplasms; Thrombocytopenia; Vomiting | 1997 |
The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group.
Topics: Anemia; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Drug Combinations; Etoposide; Female; Forecasting; Humans; Leucovorin; Male; Nausea; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1997 |
Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Indazoles; Leucovorin; Male; Middle Aged; Prognosis; Quality of Life; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 1998 |
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Double-Blind Method; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1998 |
Weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin: an effective chemotherapy in advanced gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Stomach Neoplasms; Survival Rate | 1998 |
Phase II study of the modified regimen of etoposide, leucovorin and 5-fluorouracil for patients with advanced gastric cancer.
Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Levoleucovorin; Male; Middle Aged; Prognosis; Stomach Neoplasms; Survival Analysis | 1998 |
Phase I-II study of 5-fluorouracil, leucovorin, doxorubicin, methotrexate, and long-term oral etoposide (FLAME) in unresectable or metastatic gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Stomach Neoplasms; Survival Analysis | 1998 |
A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. Turkish Oncology Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Prospective Studies; Regression Analysis; Stomach Neoplasms; Survival Analysis | 1998 |
Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: the SAKK experience. Swiss Group for Clinical Cancer Research (SAKK).
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Hematologic Diseases; Humans; Male; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 1998 |
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Levoleucovorin; Male; Middle Aged; Stomach Neoplasms; Survival Analysis | 1999 |
Combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with locoregional and metastatic gastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Etoposide; Female; Fluorouracil; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leucovorin; Levoleucovorin; Male; Middle Aged; Stomach Neoplasms | 1999 |
Combined paclitaxel, cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal Neoplasms; Esophagogastric Junction; Etoposide; Female; Humans; Male; Middle Aged; Paclitaxel; Stomach Neoplasms; Survival Rate; Treatment Outcome | 1999 |
Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Esophagogastric Junction; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Proportional Hazards Models; Stomach Neoplasms; Survival Analysis | 1999 |
Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Stomach Neoplasms; Survival Analysis | 1999 |
Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Etoposide; Female; Hot Temperature; Humans; Male; Middle Aged; Mitomycin; Multivariate Analysis; Peritoneal Cavity; Peritoneal Neoplasms; Proportional Hazards Models; Stomach Neoplasms; Treatment Outcome | 1999 |
[Arterial infusion therapy with implantable port for inoperable hepatobiliary tumors].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Colonic Neoplasms; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms | 1999 |
Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282.
Topics: Aclarubicin; Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Etoposide; Female; Humans; Male; Mitoxantrone; Organometallic Compounds; Spiro Compounds; Stomach Neoplasms | 1999 |
Successful initial treatment with weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin chemotherapy in advanced gastric cancer patients with disseminated intravascular coagulation.
Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disseminated Intravascular Coagulation; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Stomach Neoplasms; Survival Rate | 2000 |
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the Europe
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Levoleucovorin; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Stomach Neoplasms; Survival Analysis | 2000 |
[Evaluation of nervous system disorders during the course of gastric carcinoma on the basis of clinical electrophysiologic analysis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Electrophysiology; Epirubicin; Etoposide; Evoked Potentials, Auditory; Evoked Potentials, Auditory, Brain Stem; Evoked Potentials, Visual; Female; Fluorouracil; Humans; Male; Middle Aged; Nervous System Diseases; Paraneoplastic Syndromes; Stomach Neoplasms | 1999 |
The relationship between improved prognosis in gastric cancer patients in the last 25 years and changing methods of surgical and combined treatment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Staging; Pilot Projects; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate | 2000 |
Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 2001 |
[FLEP therapy for advanced and recurrent gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms; Survival Rate | 2001 |
[Twenty-year experience with multimodal treatment of gastric cancer patients in Poland].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Fluorouracil; Gastrectomy; Humans; Immunotherapy; Lymph Node Excision; Male; Middle Aged; Mitomycin; Palliative Care; Poland; Prognosis; Prospective Studies; Regression Analysis; Stomach Neoplasms; Survival Analysis; Time Factors; Treatment Outcome | 2001 |
Population pharmacokinetics and pharmacodynamics of oral etoposide.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Availability; Breast Neoplasms; Creatinine; Cross-Over Studies; Etoposide; Female; Humans; Injections, Intravenous; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Models, Biological; Software; Stomach Neoplasms | 2001 |
[Preliminary clinical comparison of HLF and ELF regimen in the treatment of advanced gastric carcinoma in middle-aged and elderly patients].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Stomach Neoplasms | 2000 |
A phase II study of etoposide, doxorubicin, and carboplatin in the treatment of advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Etoposide; Female; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Stomach Neoplasms; Survival Analysis | 2002 |
Polysaccharides isolated from Echinacea purpurea herba cell cultures to counteract undesired effects of chemotherapy--a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Echinacea; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Leukocyte Count; Leukopenia; Lymphocytes; Male; Middle Aged; Phytotherapy; Pilot Projects; Plant Extracts; Polysaccharides; Stomach Neoplasms; Treatment Outcome | 2002 |
Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients.
Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Follow-Up Studies; Humans; Immunohistochemistry; Male; Middle Aged; Stomach Neoplasms; Survival Analysis | 2002 |
Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: efficacy of therapy and value of serum tumor markers.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Disease-Free Survival; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Levoleucovorin; Male; Middle Aged; Prognosis; Stomach Neoplasms; Survival Rate; Treatment Outcome | 2002 |
Etoposide (E) + epirubicin (E) + cisplatin (P) combination chemotherapy (EEP) in advanced gastric cancer: negative impact on clinical outcome. Spanish Cooperative Group for GI Tumor Therapy (T.T.D.).
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Treatment Outcome | 1992 |
Evaluation of oral etoposide in patients with metastatic gastric carcinoma: a preliminary report.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Carcinoma; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms | 1992 |
Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Analysis | 1992 |
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Prospective Studies; Stomach Neoplasms; Survival Analysis | 1992 |
Association of epirubicin, etoposide and cisplatin in gastric cancer. A phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Humans; Middle Aged; Stomach Neoplasms | 1991 |
Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)".
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Etoposide; Female; Germany, West; Humans; Lymphatic Metastasis; Male; Middle Aged; Multicenter Studies as Topic; Reoperation; Stomach Neoplasms; Survival Rate | 1990 |
[Combination chemotherapy with etoposide, ADM, and CDDP (EAP) for advanced gastric cancer].
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms | 1990 |
[Effect of PMUE therapy (CDDP, MMC, UFT, etoposide) in terminal gastric cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Gastrectomy; Humans; Injections, Intravenous; Japan; Male; Middle Aged; Mitomycin; Mitomycins; Remission Induction; Stomach Neoplasms; Survival Rate; Tegafur; Terminal Care; Uracil | 1990 |
Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Laparotomy; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Remission Induction; Stomach Neoplasms | 1989 |
205 other study(ies) available for etoposide and Cancer of Stomach
| Article | Year |
|---|---|
Studies on quinones. Part 47. Synthesis of novel phenylaminophenanthridinequinones as potential antitumor agents.
Topics: Aniline Compounds; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Fibroblasts; Humans; Inhibitory Concentration 50; Lung Neoplasms; Molecular Structure; Phenanthridines; Quinones; Stomach Neoplasms; Structure-Activity Relationship; Urinary Bladder Neoplasms | 2011 |
(S)-Erypoegin K, an isoflavone isolated from Erythrina poeppigiana, is a novel inhibitor of topoisomerase IIα: Induction of G2 phase arrest in human gastric cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Proliferation; Cell Survival; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Erythrina; G2 Phase Cell Cycle Checkpoints; Humans; Molecular Docking Simulation; Molecular Structure; Stomach Neoplasms; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2021 |
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
Topics: Etoposide; Gastrointestinal Neoplasms; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Platinum; Prognosis; Retrospective Studies; Stomach Neoplasms | 2023 |
Adjuvant chemotherapy for patients with gastric neuroendocrine carcinomas or mixed adenoneuroendocrine carcinomas.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Propensity Score; Stomach Neoplasms; Survival Analysis | 2020 |
A case report of advanced gastric small cell carcinoma with neoadjuvant chemotherapy followed by radical total gastrectomy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Quality of Life; Stomach Neoplasms; Treatment Outcome | 2020 |
Trifunctional Graphene Quantum Dot@LDH Integrated Nanoprobes for Visualization Therapy of Gastric Cancer.
Topics: Etoposide; Graphite; Humans; Hydroxides; Quantum Dots; Stomach Neoplasms; Tumor Microenvironment | 2021 |
Inhibition of protein PMP22 enhances etoposide-induced cell apoptosis by p53 signaling pathway in Gastric Cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Etoposide; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Lentivirus; Male; Mice; Middle Aged; Myelin Proteins; Plasmids; Real-Time Polymerase Chain Reaction; RNA Interference; Signal Transduction; Stomach Neoplasms; Transfection; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2021 |
Anti-HER2 monoclonal antibodies intensify the susceptibility of human gastric cancer cells to etoposide by promoting apoptosis, but not autophagy.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Etoposide; Humans; Receptor, ErbB-2; Stomach Neoplasms; Trastuzumab; Tumor Cells, Cultured | 2021 |
Induction of apoptotic DNA fragmentation mediated by mitochondrial pathway with caspase-3-dependent BID cleavage in human gastric cancer cells by a new nitroxyl spin-labeled derivative of podophyllotoxin.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Cytochromes c; DNA Fragmentation; Etoposide; Fluorouracil; Humans; Mitochondria; Podophyllotoxin; Spin Labels; Stomach Neoplasms | 2017 |
Primary gastric small cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cardia; CD56 Antigen; Cisplatin; Etoposide; Gastric Fundus; Gastroscopy; Humans; Immunohistochemistry; Keratin-7; Male; Middle Aged; Stomach Neoplasms; Synaptophysin | 2017 |
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Retrospective Studies; Stomach Neoplasms | 2018 |
[Conversion Therapy Using Etoposide and Cisplatin Chemotherapy for Liver Metastases from Advanced Gastric Mixed Adenoneuroendocrine Carcinoma - A Case Report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms | 2017 |
Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3).
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Etoposide; Female; Humans; Infusions, Intravenous; Intestinal Neoplasms; Kaplan-Meier Estimate; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Proportional Hazards Models; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2018 |
The molecular mechanism of anticancer action of novel octahydropyrazino[2,1-a:5,4-a']diisoquinoline derivatives in human gastric cancer cells.
Topics: Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Topoisomerases, Type II; DNA, Superhelical; Dose-Response Relationship, Drug; Etoposide; Extracellular Signal-Regulated MAP Kinases; Humans; Isoquinolines; Models, Biological; Proto-Oncogene Proteins c-akt; Stomach Neoplasms; Time Factors; Tumor Suppressor Protein p53 | 2018 |
A Rare Case of Primary Histiocytic Sarcoma of the Stomach.
Topics: Abdomen; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Female; Gastrectomy; Gastroscopy; Histiocytic Sarcoma; Humans; Lymph Node Excision; Lymph Nodes; Neoplasm Recurrence, Local; Prednisolone; Retroperitoneal Space; Salvage Therapy; Stomach Neoplasms; Tomography, X-Ray Computed; Vincristine | 2018 |
Metastasis of osteosarcoma to stomach made clinically evident by hematemesis: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Gastrectomy; Hematemesis; Humans; Ifosfamide; Male; Neoplasm Staging; Osteosarcoma; Prognosis; Stomach Neoplasms | 2013 |
New advances in the treatment of gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Docetaxel; Doxorubicin; Drug Combinations; Etoposide; Fluorouracil; Humans; Leucovorin; Levoleucovorin; Methotrexate; Organoplatinum Compounds; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur | 2004 |
miR-375 targets the p53 gene to regulate cellular response to ionizing radiation and etoposide in gastric cancer cells.
Topics: 3' Untranslated Regions; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Base Sequence; Cell Cycle Checkpoints; Cell Proliferation; Cell Transformation, Neoplastic; Etoposide; Gene Expression; HCT116 Cells; Humans; MCF-7 Cells; Mice; Mice, Nude; MicroRNAs; Neoplasm Transplantation; RNA Interference; Stomach Neoplasms; Tumor Burden; Tumor Suppressor Protein p53 | 2013 |
Sequential chemotherapies for advanced gastric cancer: a retrospective analysis of 111 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Deoxycytidine; Docetaxel; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fluorouracil; Gemcitabine; Germany; Hospitals, University; Humans; Irinotecan; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Prognosis; Retrospective Studies; Salvage Therapy; Stomach Neoplasms; Taxoids; Treatment Outcome | 2013 |
Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway.
Topics: Apoptosis; Cell Line; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Etoposide; Humans; Intracellular Space; Lipids; Mitochondria; Nanoparticles; Particle Size; Stomach Neoplasms | 2014 |
Insulin-like growth factor binding protein-3 enhances etoposide-induced cell growth inhibition by suppressing the NF-κB activity in gastric cancer cells.
Topics: Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 3; NF-kappa B; Signal Transduction; Stomach Neoplasms | 2015 |
Education and imaging. Gastrointestinal: Gastric involvement in disseminated lymphadenopathic Kaposi sarcoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Doxorubicin; Endoscopy, Digestive System; Etoposide; Humans; Interferons; Male; Paclitaxel; Palliative Care; Sarcoma, Kaposi; Stomach Neoplasms | 2015 |
Ginkgo biloba extract enhances chemotherapy sensitivity and reverses chemoresistance through suppression of the KSR1-mediated ERK1/2 pathway in gastric cancer cells.
Topics: Aged; Apoptosis; Cell Line, Tumor; Cisplatin; DNA Copy Number Variations; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Ginkgo biloba; Humans; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oxidative Stress; Plant Extracts; Protein Kinases; Signal Transduction; Stomach Neoplasms | 2015 |
Etoposide-loaded nanostructured lipid carriers for gastric cancer therapy.
Topics: Animals; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; Etoposide; Humans; Lipids; Mice; Nanostructures; Particle Size; Stomach Neoplasms | 2016 |
Application of FLEEOX Preoperative Chemotherapy via Intra-arterial and Intravenous Administration in Treatment of Unresectable Locally Advanced Gastric Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Prognosis; Remission Induction; Stomach Neoplasms; Survival Rate | 2016 |
Germ Cell Tumor Targeting Chemotherapy in Gastric Adenocarcinoma with an Endodermal Sinus Tumor Component: A Case Report.
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Capecitabine; Cisplatin; Endodermal Sinus Tumor; Etoposide; Humans; Male; Neoplasm, Residual; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Tomography, X-Ray Computed | 2017 |
Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Curcumin; Drug Carriers; Drug Delivery Systems; Etoposide; Humans; Lipids; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Particle Size; Stomach Neoplasms | 2016 |
[Recurrent Gastric Carcinoma(Endocrine Cell Type)Successfully Treated with Multidisciplinary Therapy - A Case Report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Etoposide; Female; Gastrectomy; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Recurrence; Stomach Neoplasms | 2016 |
Synchronous small-cell lung cancer and gastrointestinal stromal tumor: a case report.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Doxorubicin; Etoposide; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Ifosfamide; Imatinib Mesylate; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Palliative Care; Piperazines; Pyrimidines; Small Cell Lung Carcinoma; Stomach Neoplasms | 2009 |
Cutaneous metastasis of gastric adenocarcinoma: an exuberant and unusual clinical presentation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cachexia; Carcinoma, Signet Ring Cell; Etoposide; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Skin Neoplasms; Spinal Neoplasms; Stomach Neoplasms; Treatment Failure | 2008 |
"Burned out" testicular seminoma presenting as a primary gastric malignancy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Diagnosis, Differential; Etoposide; Gastrectomy; Gastroscopy; Humans; Ifosfamide; Immunohistochemistry; Male; Middle Aged; Neoplasms, Unknown Primary; Orchiectomy; Positron-Emission Tomography; Seminoma; Stomach Neoplasms; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2009 |
Gastrointestinal hemorrhage as the first manifestation of metastatic extragonadal choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Choriocarcinoma; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Combined Modality Therapy; Etoposide; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Ifosfamide; Lung Neoplasms; Male; Occipital Lobe; Remission Induction; Retroperitoneal Neoplasms; Stomach Neoplasms; Supratentorial Neoplasms; Thoracic Surgery, Video-Assisted | 2009 |
Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromones; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Humans; K562 Cells; Leukemia; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Stomach Neoplasms; Vincristine | 2009 |
[Gastric metastasis from small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Fatal Outcome; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Pneumonia; Stomach Neoplasms; Vincristine | 2009 |
Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Etoposide; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Failure | 2010 |
[Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case].
Topics: Adenocarcinoma; alpha-Fetoproteins; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations; Etoposide; Fluorouracil; Gastrectomy; Humans; Immunohistochemistry; Leucovorin; Liver Neoplasms; Male; Middle Aged; Oxonic Acid; Remission Induction; Stomach Neoplasms; Tegafur | 2009 |
Primary small cell carcinoma of the stomach successfully treated with cisplatin and etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Male; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
Rofecoxib augments anticancer effects by reversing intrinsic multidrug resistance gene expression in BGC-823 gastric cancer cells.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cisplatin; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Fluorouracil; Gene Expression Regulation; Glutathione S-Transferase pi; Humans; Immunoblotting; Lactones; Multidrug Resistance-Associated Proteins; Reverse Transcriptase Polymerase Chain Reaction; Stomach Neoplasms; Sulfones | 2010 |
Potentiation of etoposide-induced apoptosis in HeLa cells by co-treatment with KG-135, a quality-controlled standardized ginsenoside formulation.
Topics: Androstadienes; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Etoposide; Female; Ginsenosides; HeLa Cells; Humans; Korea; Liver Neoplasms; Medicine, East Asian Traditional; Membrane Potentials; Mitochondria; Mycotoxins; Phosphoserine; Stomach Neoplasms; Wortmannin | 2010 |
[Gastric yolk sac tumor].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bleomycin; Chemotherapy, Adjuvant; Choriocarcinoma; Cisplatin; Endodermal Sinus Tumor; Etoposide; Humans; Male; Middle Aged; Stomach Neoplasms | 2010 |
A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Camptothecin; Cell Proliferation; Deoxycytidine; DNA-Binding Proteins; Drug Resistance, Neoplasm; Drug Synergism; Endonucleases; Etoposide; Gemcitabine; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Quinolines; Receptor, Fibroblast Growth Factor, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2011 |
RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Guanine Nucleotide Dissociation Inhibitors; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-bcl-2; rho Guanine Nucleotide Dissociation Inhibitor alpha; rho Guanine Nucleotide Dissociation Inhibitor beta; rho-Specific Guanine Nucleotide Dissociation Inhibitors; RNA, Small Interfering; Staurosporine; Stomach Neoplasms; Transfection; Tumor Suppressor Proteins; Up-Regulation | 2011 |
Knockdown of metallopanstimulin-1 inhibits NF-κB signaling at different levels: the role of apoptosis induction of gastric cancer cells.
Topics: Antigens, Differentiation; Apoptosis; Cell Line, Tumor; Cell Proliferation; Etoposide; HEK293 Cells; Humans; I-kappa B Kinase; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Metalloproteins; NF-kappa B; Nuclear Proteins; Phosphorylation; Ribosomal Proteins; RNA Interference; RNA-Binding Proteins; RNA, Small Interfering; Stomach Neoplasms; Transcription Factor RelA | 2012 |
Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-X Protein; Cell Growth Processes; Cell Line, Tumor; Curcumin; DNA, Neoplasm; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Humans; I-kappa B Proteins; Immunohistochemistry; In Situ Nick-End Labeling; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms; Transcription Factor RelA | 2011 |
[Acquired ichthyosis and haematological malignancies: five cases].
Topics: Adult; Aged; Allopurinol; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematologic Neoplasms; Hodgkin Disease; Humans; Ichthyosis; Imatinib Mesylate; Leukemia, Myeloid, Accelerated Phase; Lung Neoplasms; Lymphoma, B-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Parotid Neoplasms; Piperazines; Platelet Aggregation Inhibitors; Prednisone; Procarbazine; Pyrimidines; Retrospective Studies; Rituximab; Schizophrenia; Stomach Neoplasms; Vincristine | 2012 |
Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cisplatin; Etoposide; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Muscle Proteins; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms | 2012 |
Octarepeat peptides of prion are essential for multidrug resistance in gastric cancer cells.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Cisplatin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Glutathione; Glutathione Peroxidase; Glutathione Transferase; Humans; Inhibitory Concentration 50; Prions; PrPC Proteins; RNA, Small Interfering; Stomach Neoplasms; Superoxide Dismutase; Transfection; Tumor Cells, Cultured | 2012 |
Small cell carcinoma of gastro-oesophageal junction with remarkable response to chemo-radiotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Esophagogastric Junction; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Remission Induction; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Comparison of efficacy of different route of administration of chemotherapy on unresectable, advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Routes; Epirubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Injections, Intra-Arterial; Injections, Intravenous; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prognosis; Stomach Neoplasms; Survival Rate | 2012 |
Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells.
Topics: Actins; Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Cell Membrane; Cell Movement; Cisplatin; Cytoskeleton; Etoposide; Guanine Nucleotide Exchange Factors; Humans; Myosin Light Chains; Neoplasm Invasiveness; Neoplasm Metastasis; Paclitaxel; Phosphorylation; Rho Guanine Nucleotide Exchange Factors; rho-Associated Kinases; rhoA GTP-Binding Protein; Stomach Neoplasms; Vincristine | 2012 |
Pathological complete response and two-year disease-free survival in a primary gastric choriocarcinoma patient with advanced liver metastases treated with germ cell tumor-based chemotherapy: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Choriocarcinoma, Non-gestational; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Disease-Free Survival; Docetaxel; Etoposide; Fluorouracil; Humans; Liver Neoplasms; Male; Neoplasm, Residual; Stomach Neoplasms; Survival Analysis; Taxoids | 2012 |
Local recurrence of gastric cancer after total gastrectomy: an unusual presentation.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Etoposide; Fluorouracil; Gastrectomy; Humans; Levoleucovorin; Male; Neoplasm Recurrence, Local; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Identification of transporters associated with Etoposide sensitivity of stomach cancer cell lines and methotrexate sensitivity of breast cancer cell lines by quantitative targeted absolute proteomics.
Topics: Biological Transport; Breast Neoplasms; Carrier Proteins; Cell Line, Tumor; Etoposide; Female; Humans; MCF-7 Cells; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Multidrug Resistance-Associated Proteins; Propionates; Proteomics; Quinolines; Replication Protein C; Stomach Neoplasms | 2013 |
[A case of lymph node recurrence of endocrine cell carcinoma of stomach effectively treated with carboplatin and etoposide].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Gastrectomy; Humans; Lymphatic Metastasis; Neoplasm Staging; Recurrence; Stomach Neoplasms | 2012 |
Quantification and study of the L-DOPA decarboxylase expression in gastric adenocarcinoma cells treated with chemotherapeutic substances.
Topics: Adenocarcinoma; Antineoplastic Agents; Camptothecin; Cisplatin; Dopa Decarboxylase; Dose-Response Relationship, Drug; Etoposide; Fluorouracil; Gene Expression Regulation, Enzymologic; Humans; Irinotecan; Leucovorin; Paclitaxel; Real-Time Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms | 2013 |
[Gastric interdigitating reticulum cell sarcoma: unusual presentation of a histiocytic tumor].
Topics: Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Cytarabine; Diagnosis, Differential; Etoposide; Gastrectomy; Histiocytes; Humans; Immunohistochemistry; Male; Methylprednisolone; Middle Aged; Sarcoma; Stomach Neoplasms | 2002 |
[A new combination therapy with low-dose FP and daily oral administration of low-dose etoposide--a report of 2 cases].
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Humans; Male; Quality of Life; Stomach Neoplasms | 2002 |
Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Lung Neoplasms; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Prednisone; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
[A case of advanced gastric adenocarcinoma with mild elevation of serum SCC that responded remarkably to adjuvant chemotherapy of ADM, CDDP, ETP and 5-FU (ACVF)].
Topics: Adenocarcinoma; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Combinations; Etoposide; Fluorouracil; Gastrectomy; Humans; Lymphatic Metastasis; Male; Oxonic Acid; Pyridines; Remission Induction; Serpins; Stomach Neoplasms; Tegafur | 2003 |
Bcl-w is expressed in a majority of infiltrative gastric adenocarcinomas and suppresses the cancer cell death by blocking stress-activated protein kinase/c-Jun NH2-terminal kinase activation.
Topics: Adenocarcinoma; Apoptosis Regulatory Proteins; Cell Death; Cell Survival; Enzyme Activation; Etoposide; fas Receptor; Humans; Hydrogen Peroxide; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasm Staging; Protein Biosynthesis; Proteins; Stomach Neoplasms; Tumor Cells, Cultured | 2003 |
A case of aggressive neuroendocrine carcinoma of the stomach.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Fluorouracil; Gastrectomy; Humans; Liver Neoplasms; Male; Middle Aged; Omentum; Pancreatic Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms; Tomography, X-Ray Computed | 2003 |
A novel carbazole topoisomerase II poison, ER-37328: potent tumoricidal activity against human solid tumors in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carbazoles; Colonic Neoplasms; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Female; Humans; Lung Neoplasms; Macromolecular Substances; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Protein Binding; Pyrimidines; Stomach Neoplasms; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |
Exogenous wild-type p16INK4A gene induces delayed cell proliferation and promotes chemosensitivity through decreased pRB and increased E2F-1 expressions.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p16; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; Etoposide; Fluorouracil; Humans; Retinoblastoma Protein; Stomach Neoplasms; Transcription Factors | 2003 |
[Thirteen years' survival in a patient with isolated skin metastases of a gastric carcinoma. What kind of disease is that?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Etoposide; Fatal Outcome; Female; Fluorouracil; Gastroenterostomy; Humans; Leucovorin; Middle Aged; Radioisotope Teletherapy; Shoulder; Skin Neoplasms; Stomach Neoplasms; Stomach Ulcer; Survivors | 2003 |
Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gastrectomy; Gastric Mucosa; Humans; Immunohistochemistry; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Probability; Prognosis; Risk Assessment; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 2003 |
Mobilization of peripheral blood stem cells (PBSCs) after etoposide, adriamycin and cisplatin therapy, and a multimodal cell therapy approach with PBSCs in advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cancer Vaccines; Carcinoembryonic Antigen; Cell Line, Tumor; Cell Separation; Cisplatin; Combined Modality Therapy; Dendritic Cells; Doxorubicin; Etoposide; Flow Cytometry; Hematopoietic Stem Cell Mobilization; Humans; Immunotherapy; Lymphatic Metastasis; Male; Middle Aged; Neutrophils; Stem Cells; Stomach Neoplasms; Time Factors | 2004 |
[A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Etoposide; Humans; Injections, Intraperitoneal; Male; Middle Aged; Mitomycin; Peritoneal Neoplasms; Peritonitis; Stomach Neoplasms; Tegafur; Tumor Cells, Cultured; Uracil | 2004 |
FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 2004 |
[A case of gastric endocrine cell carcinoma with neck lymph node metastasis resected after neoadjuvant chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Female; Gastrectomy; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neck; Stomach Neoplasms | 2004 |
Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Gastrectomy; Humans; Laparoscopy; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Preoperative Care; Prognosis; Proportional Hazards Models; Stomach Neoplasms; Survival Rate | 2005 |
Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Intraoperative Care; Male; Middle Aged; Mitomycin; Peritoneum; Postoperative Complications; Stomach Neoplasms; Survival Analysis | 2005 |
[Successful treatment with etoposide by oral administration for recurrence of gastric diffuse large B-cell lymphoma after surgical resection--a case report].
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Etoposide; Female; Gastrectomy; Humans; Ileal Neoplasms; Liver Neoplasms; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Remission Induction; Stomach Neoplasms | 2005 |
Regulation of multidrug resistance by ribosomal protein l6 in gastric cancer cells.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Resistance, Multiple; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Glutathione; Glutathione Transferase; Humans; Proto-Oncogene Proteins c-bcl-2; Ribosomal Proteins; Stomach Neoplasms; Transfection; Vincristine | 2005 |
[Peritoneal dissemination of scirrhous type 4 gastric cancers].
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Etoposide; Female; Gastrectomy; Humans; Immunotherapy; Male; Middle Aged; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Pyridines; Stomach Neoplasms; Survival Rate; Tegafur | 2005 |
[Intraperitoneal chemotherapy in gastric cancer patients with peritoneal dissemination].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Gastrectomy; Humans; Hyperthermia, Induced; Infusions, Parenteral; Mitomycins; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms | 2005 |
Activation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cells.
Topics: Androstadienes; Antineoplastic Agents, Phytogenic; Cell Division; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Stomach Neoplasms; Tumor Suppressor Protein p53; Wortmannin | 2006 |
[How to treat well differentiated endocrine carcinoma with a high proliferative index? A case of gastric endocrine carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neuroendocrine Tumors; Stomach Neoplasms | 2006 |
[A case of inoperable gastric small cell carcinoma effectively treated by chemotherapy and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Drug Administration Schedule; Drug Combinations; Etoposide; Humans; Irinotecan; Lymph Nodes; Lymphatic Metastasis; Male; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur | 2006 |
Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Female; Gastrectomy; Humans; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Prognosis; Stomach Neoplasms; Survival Rate | 2006 |
[Protein kinase B inhibitor enhance sensitivity of gastric cancer cell to etoposide].
Topics: Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Etoposide; Humans; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Stomach Neoplasms | 2007 |
[Antitumor effects of specific cyclooxygenase inhibitors combined with chemotherapeutic agents on gastric cancer cells in vitro].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Fluorouracil; Humans; Lactones; Pyrazoles; Stomach Neoplasms; Sulfonamides; Sulfones | 2007 |
Inhibition of Akt/protein kinase B activity sensitizes moderately- to un-differentiated gastric cancer cells to chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Etoposide; Humans; Proto-Oncogene Proteins c-akt; Stomach Neoplasms | 2007 |
Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Etoposide; Humans; I-kappa B Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphatidylinositol 3-Kinases; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Stomach Neoplasms; Transfection | 2008 |
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cisplatin; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Microarray Analysis; MicroRNAs; Mitomycin; Proto-Oncogene Proteins c-bcl-2; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Stomach Neoplasms; Up-Regulation; Vincristine | 2008 |
[A case of gastric cancer responding well to MTX/5-FU (methotrexate/5-fluorouracil) and PMUE (CDDP, MMC, UFT, etoposide) therapies upon lymphnode recurrence].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1995 |
[A case of AFP (alpha-fetoprotein) producing gastric cancer successfully treated with EAP (etoposide, adriamycin, cisplatin) therapy].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms | 1994 |
[Chemohyperthermic peritoneal perfusion and subtotal peritonectomy for peritonitis carcinomatosa in gastroenteric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Mitomycin; Neoplasm Invasiveness; Perfusion; Peritoneal Lavage; Peritoneal Neoplasms; Peritoneum; Peritonitis; Stomach Neoplasms | 1995 |
Chemotherapy of human small-cell gastrointestinal carcinoma xenografts in nude mice.
Topics: Aged; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Esophageal Neoplasms; Etoposide; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitomycin; Neoplasm Transplantation; Phosphopyruvate Hydratase; Remission Induction; Stomach Neoplasms; Transplantation, Heterologous | 1995 |
[Etoposide, epirubicin and cisplatin (EEP) combination in metastatic cancers of the cardia and the stomach. Groupe de recherche en cancérologie du Nord (GRECNO)].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardia; Cisplatin; Epirubicin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Treatment Outcome | 1994 |
[Evaluation of 5-FU, leucovorin, etoposide, and cisplatin (FLEP) chemotherapy by hepatic artery injection in the treatment of multiple liver metastases from gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms | 1995 |
Five-drug combination chemotherapy (FAPEL) for advanced gastric cancer: a pilot study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Pilot Projects; Stomach Neoplasms | 1994 |
[A case of cutaneous and brain metastasis of gastric carcinoma, treated effectively by chemotherapy with CDDP, MMC, etoposide and 5'-DFUR].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Drug Administration Schedule; Etoposide; Female; Floxuridine; Humans; Infusions, Intravenous; Mitomycin; Neoplasm Invasiveness; Skin Neoplasms; Stomach Neoplasms; Treatment Outcome | 1994 |
[A case of curatively operated gastric cancer with peritonitis carcinomatosa treated by intraperitoneal administration of CDDP.Etoposide and EAP therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Gastrectomy; Humans; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Peritonitis; Stomach Neoplasms | 1994 |
Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Analysis; Time Factors; Treatment Failure | 1993 |
[A case of gastric malignant lymphoma markedly responding to chronic daily and oral administration of low-dose etoposide].
Topics: Administration, Oral; Aged; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Salvage Therapy; Stomach Neoplasms | 1993 |
[Successful treatment of two patients with advanced gastric cancer by neoadjuvant chemotherapy with EAP regimen].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Hepatic Artery; Humans; Infusion Pumps, Implantable; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms | 1994 |
[Continuous hyperthermic peritoneal perfusion (CHPP) for prevention or treatment of peritoneal dissemination].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Thiosulfates | 1993 |
[Recurrence and survival rate of advanced gastric cancer after preoperative intraarterial EAP I injection therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Humans; Injections, Intraperitoneal; Neoplasm Recurrence, Local; Preoperative Care; Stomach Neoplasms; Survival Rate | 1993 |
[Intraarterial infusion chemotherapy for recurrent or unresectable gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Mitomycin; Peritonitis; Prognosis; Stomach Neoplasms; Survival Rate | 1993 |
[Etoposide, doxorubicin, cisplatin and 5-FU (EAP-F) therapy of advanced gastric cancer--its antitumor effect and evaluation of quality of life].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Fluorouracil; Gastrectomy; Humans; Quality of Life; Stomach Neoplasms; Survival Rate | 1993 |
[A case of metastatic cancer of the stomach from small cell carcinoma of the lung].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Male; Stomach Neoplasms; Vincristine | 1993 |
[Evaluation of the combination of chemotherapy with etoposide, adriamycin and cisplatin (EAP) in advanced or recurrent gastric cancer].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Liver Neoplasms; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Stomach Neoplasms; Survival Rate; Vomiting | 1993 |
[A case of gastric cancer with multiple liver metastases showing marked efficacy of preoperative and postoperative chemotherapy with CDDP, MMC and UFT(PMU), or CDDP, MMC, UFT and etoposide (PMUE)].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Hepatectomy; Hepatic Artery; Humans; Infusion Pumps; Liver Neoplasms; Lymphatic Metastasis; Male; Mitomycin; Postoperative Care; Preoperative Care; Stomach Neoplasms; Tegafur; Uracil | 1993 |
EAP in advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms | 1993 |
[A case of early gastric cancer transformed from adenoma by chemotherapy and radiotherapy].
Topics: Adenoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Lymphoma; Male; Neoplasms, Second Primary; Prednisolone; Stomach Neoplasms; Tegafur; Uracil; Vincristine | 1996 |
[Combined chemotherapy with MMC, ADM, CDDP, etoposide (VP-16) and 5'-DFUR, (MACVD therapy) as a second-line chemotherapy for metastatic gastric cancer: three cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Floxuridine; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Stomach Neoplasms | 1996 |
[Clinical implication of p53 analysis on DNA-damaging therapies of human gastric and rectal cancers].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cisplatin; DNA Damage; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Rectal Neoplasms; Stomach Neoplasms; Tumor Suppressor Protein p53 | 1996 |
[A case of advanced gastric cancer with multiple liver metastasis successfully treated with combination chemotherapy using UFT, CDDP and etoposide].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Etoposide; Humans; Injections, Intravenous; Lentinan; Leukopenia; Liver Neoplasms; Male; Nausea; Stomach Neoplasms; Tegafur; Thrombocytopenia; Uracil | 1996 |
[A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1996 |
The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers.
Topics: Antineoplastic Agents; Camptothecin; Cisplatin; Colonic Neoplasms; Doxorubicin; Etoposide; Genes, MDR; Humans; Irinotecan; Mitomycin; Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Tumor Cells, Cultured; Verapamil; Vincristine | 1996 |
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Male; Melphalan; Methotrexate; Prednisone; Recurrence; Remission Induction; Retreatment; Salvage Therapy; Stomach Neoplasms; Transplantation Conditioning; Tumor Lysis Syndrome; Vincristine | 1997 |
CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Palliative Care; Prognosis; Prospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Treatment Outcome | 1997 |
High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prednisone; Procarbazine; Prospective Studies; Radiotherapy, Adjuvant; Stomach Neoplasms; Vincristine | 1996 |
Down-regulation of topoisomerase II by camptothecin does not prevent additive activity of the topoisomerase II inhibitor etoposide in vitro.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Camptothecin; Cell Cycle; Cell Survival; DNA Topoisomerases, Type II; Doxorubicin; Drug Interactions; Etoposide; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Lung Neoplasms; Paclitaxel; Polymerase Chain Reaction; Rhodamines; Stomach Neoplasms; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Vincristine | 1997 |
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for metastatic gastric leiomyosarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leiomyosarcoma; Stomach Neoplasms | 1997 |
[A case of complete remission of gastric endocrine cell carcinoma with multiple bone metastasis by combination chemotherapy and high-dose chemotherapy with autologous peripheral blood stem cell transplantation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoid Tumor; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Remission Induction; Stomach Neoplasms; Vincristine | 1997 |
[Advanced gastric cancer curatively resected following combined neoadjuvant chemotherapy--report of a case].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Fluorouracil; Humans; Leucovorin; Lymph Node Excision; Lymphatic Metastasis; Male; Stomach Neoplasms | 1998 |
Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancers.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Male; Middle Aged; Stomach Neoplasms | 1998 |
Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimen.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Levoleucovorin; Male; Middle Aged; Stomach Neoplasms; Tegafur; Treatment Outcome | 1998 |
[A case of small cell carcinoma of the stomach with multiple liver and lung metastases successfully treated by combined chemotherapy with cisplatin and etoposide].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Splenectomy; Stomach Neoplasms | 1999 |
Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells.
Topics: Antineoplastic Agents; ATP-Binding Cassette Transporters; Doxorubicin; Drug Resistance, Multiple; Etoposide; Fluoresceins; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Leukotriene C4; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Probenecid; Quinolines; RNA, Messenger; Stomach Neoplasms; Tumor Cells, Cultured; Vincristine | 1999 |
[A case report: modified PMUE therapy might be effective for advanced gastric carcinoma with pulmonary carcinomatous lymphangitis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Fluorouracil; Humans; Lung Neoplasms; Lymphangitis; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Stomach Neoplasms | 1999 |
Activation and the interaction of proapoptotic genes in modulating sensitivity to anticancer drugs in gastric cancer cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Cisplatin; DNA Fragmentation; Docetaxel; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Humans; Inhibitory Concentration 50; Paclitaxel; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Signal Transduction; Stomach Neoplasms; Taxoids; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation | 1999 |
Histological indications of a favorable prognosis with far-advanced gastric carcinomas after preoperative chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Combined Modality Therapy; Drug Therapy, Combination; Etoposide; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Prognosis; Retrospective Studies; Stomach; Stomach Neoplasms; Survival Analysis; Time Factors; Treatment Outcome | 1999 |
[A case of stage IVb (H2P0N4T4) gastric cancer successfully treated with neoadjuvant chemotherapy (PMFE therapy)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Fluorouracil; Gastrectomy; Humans; Male; Mitomycin; Neoadjuvant Therapy; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2000 |
[Is it useful to perform a (67)gallium scintigraphy in the follow-up of patients with gastric lymphoma?].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Fatal Outcome; Follow-Up Studies; Gallium Radioisotopes; Gastrectomy; Gastroscopy; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Methylprednisolone; Mitoxantrone; Neoplasm Recurrence, Local; Paclitaxel; Prednisone; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Stomach Neoplasms; Stomach Ulcer; Tomography, X-Ray Computed; Vincristine | 2001 |
Surgical and combined treatment of gastric cancer--own experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Fluorouracil; Gastrectomy; Guidelines as Topic; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Palliative Care; Stomach Neoplasms; Survival Rate | 2000 |
[Hemorrhagic diathesis as initial symptom of stomach carcinoma].
Topics: Algorithms; Anemia, Hemolytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Neoplasms; Carcinoma, Signet Ring Cell; Cisplatin; Diagnosis, Differential; Disseminated Intravascular Coagulation; Etoposide; Female; Fluorouracil; Hemorrhagic Disorders; Humans; Leucovorin; Middle Aged; Neoplasm Metastasis; Precancerous Conditions; Stomach; Stomach Neoplasms; Thrombocytopenia | 2000 |
[Morphologic response evaluation of neoadjuvant chemotherapy of gastric carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate | 2000 |
Quality of life in cancer patients treated by chemotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Colorectal Neoplasms; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Neoplasms; Quality of Life; Stomach Neoplasms; Surveys and Questionnaires | 2000 |
[Curative resection of advanced gastric cancer responding to preoperative chemotherapy--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Fluorouracil; Gastrectomy; Humans; Infusion Pumps, Implantable; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Preoperative Care; Stomach Neoplasms | 2001 |
Advanced gastric cancer with multiple lymph node metastasis successfully treated with etoposide, adriamycin and cisplatin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystadenocarcinoma, Serous; Doxorubicin; Etoposide; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Stomach Neoplasms | 2001 |
Cutaneous metastases from gastric adenocarcinoma treated with combination chemotherapy producing complete response with long survival.
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Etoposide; Female; Humans; Mitomycin; Skin Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2001 |
Primary gastric choriocarcinoma: a case report and review of the literature.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Diagnosis, Differential; Etoposide; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Salvage Therapy; Stomach Neoplasms; Tomography, X-Ray Computed | 2001 |
Management of a 16-year-old boy with adenocarcinoma at the esophageal gastric junction.
Topics: Adenocarcinoma; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diagnosis, Differential; Doxorubicin; Esophagogastric Junction; Etoposide; Fluorouracil; Humans; Male; Methotrexate; Paclitaxel; Stomach Neoplasms | 2001 |
[Globalization of anti-cancer therapies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carboplatin; Cisplatin; Colorectal Neoplasms; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Neoplasms; Ovarian Neoplasms; Paclitaxel; Prostatic Neoplasms; Stomach Neoplasms | 2002 |
[A gastric cancer patient with marked para-aortic lymph node metastasis surviving more than 10 years after aggressive operation and repeated EAP chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Stomach Neoplasms; Survivors | 2002 |
Induction of apoptosis by TPA and VP-16 is through translocation of TR3.
Topics: Active Transport, Cell Nucleus; Apoptosis; DNA-Binding Proteins; Etoposide; Gene Expression; Nuclear Receptor Subfamily 4, Group A, Member 1; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Stomach Neoplasms; Tetradecanoylphorbol Acetate; Transcription Factors; Tumor Cells, Cultured | 2002 |
Enhanced expression of insulin-like growth factor binding protein-3 sensitizes the growth inhibitory effect of anticancer drugs in gastric cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Division; Etoposide; G1 Phase; Humans; Insulin-Like Growth Factor Binding Protein 3; Paclitaxel; Resting Phase, Cell Cycle; RNA, Messenger; Stomach Neoplasms; Tumor Cells, Cultured; Up-Regulation | 2002 |
The chemotherapy of metastatic gastric adenocarcinomas with hypersecretion of alpha-fetoprotein or beta-human chorionic gonadotrophin: report of two cases.
Topics: Adenocarcinoma; Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Drug Resistance, Neoplasm; Etoposide; Humans; Liver Neoplasms; Male; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Survival Analysis | 2002 |
Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Base Sequence; Cell Division; Cell Survival; Cell-Free System; Cisplatin; Daunorubicin; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Humans; Mitoxantrone; Molecular Sequence Data; Neoplasm Proteins; Peptides; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; RNA, Catalytic; RNA, Messenger; Stomach Neoplasms; Time Factors; Transfection; Tumor Cells, Cultured | 2002 |
[Clinical and therapeutic study (phase II) using VP-16/213 and methyl-CCNU in patients with inoperable, recurring or metastasizing carcinomas of the gastriointestinal tract].
Topics: Adult; Aged; Colonic Neoplasms; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Humans; Lomustine; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nitrosourea Compounds; Podophyllotoxin; Stomach Neoplasms; Terminal Care; Time Factors | 1978 |
Chemotherapy for gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Humans; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms | 1992 |
[PMUE therapy (CDDP, MMC, UFT, etoposide) for advanced gastric cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Remission Induction; Reoperation; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[A case of gastric cancer with multiple liver metastases effectively treated with PMUE (CDDP, MMC, UFT, etoposide) hepatic arterial chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[A case of gastric carcinoma with peritonitis carcinomatosa responding remarkably to etoposide, adriamycin and cisplatin (EAP) therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Cisplatin; Doxorubicin; Etoposide; Humans; Infusions, Intravenous; Male; Middle Aged; Peritonitis; Stomach Neoplasms | 1992 |
The succinate dehydrogenase inhibition test for evaluating biopsy specimens and resected tumors of advanced gastric cancer.
Topics: Aged; Biopsy; Cisplatin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Mitomycin; Stomach Neoplasms; Succinate Dehydrogenase | 1992 |
[Intraperitoneal chemotherapy of metastatic ovarian cancer].
Topics: Cisplatin; Colonic Neoplasms; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Stomach Neoplasms | 1992 |
Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric cancer: an old lesson revisited.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Humans; Methotrexate; Stomach Neoplasms; Survival Analysis | 1992 |
[Combination therapy with 5-FU, etoposide and CDDP (FEP regimen) in advanced primary and recurrent gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[A resected case of advanced gastric cancer with complete remission of liver metastasis by chronic daily administration of oral etoposide and UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Male; Mitomycin; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[Clinical evaluation of intra-arterial infusion of hyperthermo-chemotherapy in gastric cancer].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Etoposide; Fluorouracil; Humans; Hyperthermia, Induced; Infusion Pumps; Infusions, Intra-Arterial; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms | 1991 |
New developments in the treatment of gastric carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Evaluation Studies as Topic; Fluorouracil; Humans; Leucovorin; Prognosis; Stomach Neoplasms; Survival Rate | 1991 |
Discrimination of mitotic cells using anti-p105 monoclonal antibody to analyze the mode of action of etoposide and podophyllotoxin in human gastric cancer cells.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Cell Cycle; Cell Line; DNA, Neoplasm; Etoposide; Humans; Kinetics; Mitosis; Mitotic Index; Nuclear Proteins; Podophyllotoxin; Proliferating Cell Nuclear Antigen; Stomach Neoplasms | 1991 |
[New interesting chemotherapeutic regimens in advanced gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Stomach Neoplasms; Survival Rate | 1991 |
[European School of Oncology (ESO)--gastric cancer treatment strategy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Fluorouracil; Humans; Methotrexate; Prognosis; Stomach Neoplasms | 1992 |
Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Fluorouracil; Humans; Leucovorin; Premedication; Remission Induction; Stomach Neoplasms; Time Factors | 1991 |
Etoposide, doxorubicin and cisplatin in advanced or metastatic gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms | 1991 |
[In vitro chemosensitivity test using collagen gel matrix for human gastric carcinomas].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Agents; Cisplatin; Collagen; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Gels; Humans; Mitomycin; Mitomycins; Stomach Neoplasms; Tumor Cells, Cultured | 1991 |
Phase II trial of etoposide (V), adriamycin (A), and cisplatinum (P) in patients with metastatic gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Male; Stomach Neoplasms; Survival Rate | 1991 |
Combination of etoposide, adriamycin and cisplatin (EAP) in gastric cancer: association with severe toxicity.
Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Rate; Vascular Diseases | 1991 |
Combination of etoposide, adriamycin and cisplatin (EAP) in gastric cancer: association with severe toxicity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Hematologic Diseases; Humans; Male; Middle Aged; Stomach Neoplasms | 1991 |
[Clinical study of drug accumulation in gastric cancer after preoperative intra-arterial EAP II injection therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Epirubicin; Etoposide; Female; Gastric Mucosa; Humans; Injections, Intra-Arterial; Lymph Nodes; Male; Preoperative Care; Stomach Neoplasms | 1991 |
[Evaluation of effective neo-adjuvant chemotherapy (FLEP therapy) in the treatment of advanced gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Stomach Neoplasms | 1991 |
Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Middle Aged; Stomach Neoplasms; Survival Analysis | 1991 |
[Chemosensitivity test for gastric cancer by in vitro MTT assay].
Topics: Antineoplastic Agents; Carbazilquinone; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Fluorouracil; Humans; Mitomycin; Mitomycins; Stomach Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1991 |
[Intraperitoneal administration of cis-platin with arterial infusion chemotherapy of advanced and recurrent gastric cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Stomach Neoplasms | 1991 |
[CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gastrectomy; Humans; Infusions, Parenteral; Injections, Intravenous; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Peritonitis; Stomach Neoplasms; Tegafur; Uracil | 1991 |
Massively bleeding gastrosplenic fistula following cytostatic chemotherapy of a malignant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Fistula; Gastric Fistula; Gastrointestinal Hemorrhage; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Splenic Diseases; Stomach Neoplasms | 1991 |
[Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Division; Cisplatin; Doxorubicin; Drug Synergism; Etoposide; Humans; Mice; Mice, Nude; Mitomycin; Neoplasm Transplantation; Nitrobenzenes; Pancreatic Neoplasms; Stomach Neoplasms | 1991 |
Weekly etoposide, methotrexate and actinomycin D, alternating with cyclophosphamide plus vincristine (EMA/CO): a phase II study in advanced gastric carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Evaluation; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Remission Induction; Stomach Neoplasms; Vincristine | 1991 |
The effectiveness of a combination of etoposide/adriamycin/cisplatin (EAP) against inoperable gastric cancer--report of a histologically proven case.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Stomach Neoplasms | 1991 |
[Evaluation of EAP (etoposide, adriamycin, cisplatin) for highly advanced gastric cancer in a neoadjuvant setting].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Etoposide; Female; Gastrectomy; Humans; Male; Middle Aged; Preoperative Care; Stomach Neoplasms; Survival Rate | 1991 |
[Application of anti-p-105 monoclonal antibody to analysis of mode of action of antitumor agents].
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Cell Cycle; Etoposide; Humans; Mitosis; Podophyllotoxin; Stomach Neoplasms; Tumor Cells, Cultured | 1991 |
[Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Preoperative Care; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1990 |
[Antitumor activity of 4-(4''-(2'',2'',6'',6''-tetramethyl-1''-piperidinyoxy)amino)-4'- demethyl epipodophyllotoxin in vitro].
Topics: Antineoplastic Agents; Dose-Response Relationship, Drug; Etoposide; Humans; Microtubule-Associated Proteins; Mitotic Index; Podophyllotoxin; Stomach Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1990 |
[A study of combined chemotherapy with MMC, ADM, CDDP, etoposide (VP-16), 5'DFUR (MAC-VD therapy) in advanced cancer and local relapse of the stomach].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Floxuridine; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Stomach Neoplasms | 1990 |
[The changes in tumor markers such as serum CEA, CA 19-9, TPA and CA 125 in the chemotherapy of patients with advanced gastric cancer].
Topics: Adolescent; Adult; Aged; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Cisplatin; Doxorubicin; Etoposide; Female; Floxuridine; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Peptides; Remission Induction; Stomach Neoplasms; Tissue Polypeptide Antigen | 1990 |
[Study on endoscopic features in responders to systemic chemotherapy in advanced gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Floxuridine; Gastroscopy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Remission Induction; Stomach Neoplasms | 1990 |
[Intra-hepato-arterial infusion chemotherapy using catheter inserted and placed in hepatic artery via the left radial artery on liver malignancy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization; Cisplatin; Colonic Neoplasms; Embolization, Therapeutic; Etoposide; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms | 1990 |
Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Etoposide; Female; Gastrectomy; Humans; Male; Middle Aged; Neutropenia; Stomach Neoplasms; Thrombocytopenia | 1990 |
New developments in the treatment of gastric carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Levoleucovorin; Male; Middle Aged; Prognosis; Remission Induction; Reoperation; Stomach Neoplasms; Survival Rate | 1990 |
A phase II study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Remission Induction; Stomach Neoplasms | 1990 |
Toxicity of etoposide, doxorubicin, and cisplatin in gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Humans; Neutropenia; Remission Induction; Stomach Neoplasms | 1990 |
EAP in advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms | 1990 |
[Effect of high dose etoposide, adriamycin, cisplatin (EAP) therapy with autologous bone marrow transplantation in gastric cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Transplantation, Autologous | 1990 |
High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac risk.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Etoposide; Female; Fluorouracil; Heart Diseases; Humans; Leucovorin; Male; Middle Aged; Remission Induction; Risk Factors; Stomach Neoplasms; Survival Rate | 1990 |
Locally advanced unresectable gastric cancer successfully resected after neoadjuvant chemotherapy with FADE regimen.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Fluorouracil; Humans; Male; Middle Aged; Stomach; Stomach Neoplasms; Tomography, X-Ray Computed | 1990 |
[Clinical study of drug accumulation in gastric cancer after preoperative intra-arterial EA'P injection therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Gastric Mucosa; Humans; Injections, Intra-Arterial; Male; Middle Aged; Preoperative Care; Stomach Neoplasms | 1990 |
[Combination chemotherapy with UFT, etoposide, CDDP, adriamycin (FEPA) in advanced gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Gastrectomy; Humans; Leukopenia; Male; Middle Aged; Remission Induction; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1989 |
[A study of combined chemotherapy with MMC, ADM, CDDP, VP-16 and 5'DFUR (MAC-VD) in advanced cancers of digestive organs].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Floxuridine; Gallbladder Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Mitomycins; Splenic Neoplasms; Stomach Neoplasms | 1989 |
[Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Remission Induction; Stomach Neoplasms; Thrombocytopenia; Vomiting | 1989 |
Advanced gastric cancer: a new combined surgical and oncological approach.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Male; Methotrexate; Middle Aged; Reoperation; Stomach Neoplasms | 1989 |
Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Etoposide; Female; Gastrectomy; Humans; Laparotomy; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Remission Induction; Reoperation; Stomach Neoplasms | 1989 |
[Intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis using totally implantable peritoneal access system].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Infusion Pumps; Infusions, Parenteral; Male; Middle Aged; Peritoneal Cavity; Peritoneal Neoplasms; Stomach Neoplasms | 1989 |
[The effect of EAP (etoposide, adriamycin, cis-platinum) on patients with advanced gastric cancer: the role of EAP as neoadjuvant chemotherapy and histopathological study on its effect].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms | 1989 |
[Advanced and recurrent gastric carcinoma: combination chemotherapy with etoposide (E), adriamycin (A), cisplatin (P) = EAP].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Remission Induction; Stomach Neoplasms | 1989 |
Pilot study of a continuous five-day intravenous infusion of etoposide concomitant with cisplatin in selected patients with advanced cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Histiocytoma, Benign Fibrous; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Stomach Neoplasms; Tongue Neoplasms | 1988 |
[FEP and FAP combination chemotherapy in advanced gastric cancer. Research Group for Gastric Cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Combination chemotherapy of UFT, etoposide and CDDP in advanced gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia L1210; Male; Mice; Middle Aged; Radiography; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[A case of gastric carcinoma remarkably responding to etoposide, adriamycin and cisplatin (EAP) therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Duodenal Ulcer; Etoposide; Gastrectomy; Humans; Male; Middle Aged; Stomach Neoplasms | 1988 |
Phase-II-study with EAP (etoposide, adriamycin, cis-platinum) in patients with primary inoperable gastric cancer and advanced disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Stomach Neoplasms | 1988 |
[A case of coexisting primary malignant lymphoma and adenocarcinoma of the stomach].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrectomy; Gastroscopy; Humans; Lymphoma; Neoplasms, Multiple Primary; Prednisolone; Stomach; Stomach Neoplasms; Vinblastine; Vincristine | 1986 |
Phase II trial of cisplatin and etoposide in adenocarcinomas of the upper gastrointestinal tract.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms | 1987 |
Combination of mitomycin C + etoposide in advanced gastric carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms | 1985 |